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Human cyclic GMP-AMP synthase (cGAS) contributes to the cellular stress response by detecting 
cytosolic double-stranded (ds)DNA and initiating defensive signaling programs. dsDNA binding 
induces cGAS dimerization and activation, which enables it convert ATP and GTP into the second 
messenger, cyclic GMP-AMP (cGAMP). cGAMP binds the downstream signaling adaptor 
Stimulator of Interferon Genes (STING) which triggers upregulation of stress response genes. 
cGAS/STING signaling results in variable cellular outcomes depending on cell type, dsDNA 
stimulus, signal strength and the duration for which the signaling axis is active. Moreover, 
dysregulated cGAS/STING signaling contributes to disease. Thus, understanding how cGAS 
activity is regulated is key to determining how cellular stress dictates cell fate and organismal 
health.  
 
Although cGAS can be activated by any length of dsDNA in vitro, cGAS discriminates against 
short dsDNAs in cells. This discrepancy is thought to arise from dsDNA-length dependent binding 
and is predicated on the notion that cGAS forms ladder-like arrays on parallel strands of DNA 
duplexes. Although cGAS binding affinity is dependent on dsDNA length, the ‘ladder’ model fails 
to explain why short dsDNA activates cGAS in vitro. Moreover, the model disregards any role 
that substrate may play in the allosteric activation mechanism, nor how cGAS concentration affects 
dsDNA-length dependent activities. For these reasons, I used recombinant, human cGAS protein 
and in vitro biochemical and biophysical tools to develop a comprehensive model that explains 
how cGAS activity is regulated. The model defines how substrate binding, cGAS self-association 
and dsDNA binding are thermodynamically linked to cGAS activity and provides a rationale for 
why dsDNA length discretion is context-dependent. The full-length enzyme operates within the 
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same allosteric network as the catalytic domain alone, with the exception that the N-terminal 
domain assists in cGAS auto- and ligand-induced dimerization. Finally, using the model as a guide, 
I determined how divalent manganese contributes to cGAS dsDNA sensing.  
 
The model defines how cGAS is intrinsically regulated and provides a rationale for how 
inflammation potentiates cGAS’s role in autoimmunity. Moreover, the model serves as a platform 
to delineate how extrinsic factors, such as post-translation modifications, affect cGAS activity.  
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To survive and prosper, cells must accomplish three main objectives: acquire nutrients, replicate 
and respond appropriately to stress. Nutrients supply the energy for cellular activities, while 
replication ensures continuation of the cell’s lineage. Why then, is stress so important? Broadly 
defined, stress is anything that perturbs cellular homeostasis, and as such, impinges on a cell’s life 
constantly. Cells are in perpetual pursuit of maintaining homeostasis. As a result, stress 
significantly contributes to the decision of when to divide and how to use energy.  
 
Cellular stress comes in many forms. Direct, physical contact can damage essential protective 
barriers, such as the cell wall, or any compartment that sequesters molecules to specific locales. 
Cells also experience perturbations in temperature and pressure, which inherently tests the 
fortitude and resilience of biological macromolecules and cellular sub- and super-structures. At 
the chemical level, cells are challenged on a regular basis by bouts of nutrient starvation, radiation, 
and microbial attacks, and, error in cellular processes like replication and protein folding can lead 
to serious issues. In all such cases, the cell can detect events that perturb homeostasis and enact a 
programmed response that leads to resolution. 
 
The immune system exemplifies stress detection and resolution. When a pathogen is detected, cells 
not only produce pro-inflammatory molecules that recruit immune cells to this site of stress, but 
they also produce anti-viral effectors that can either detect pathogens or directly inhibit them. 
Immune cell activation also coordinates maturation of the adaptive immune response of which 
prepares the entire organism for repeat stress offenses. Importantly, this concerted response hinges 
on accurate perception of stress by molecular sentinels of the innate immune system. These Pattern 
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Recognition Receptor, PRRs, are a sub-set of structurally and functionally diverse, germline-
encoded proteins and enzymes, that share the common goal of identifying molecules associated 
with stress and then initiating appropriate stress responses. 
 
Knowing the difference between self and nonself 
Distinguishing normal, host molecules (self) from particles contributed by ‘outside’ sources (non-
self; stress) is paramount to initiating the correct stress response. Phenomenologically, non-self 
can be defined in several ways. First, molecules can be chemically distinct from those typically 
created by the host cell. The bacterial cell wall is composed of many orthogonal compounds, such 
as peptidoglycan and lipopolysaccharide, that are readily detected by PRRs. Non-self can also be 
synthesized by the host. During replication, RNA viruses recruit polymerases that duplicate the 
viral genome, and in so doing, create 5’-termini baring a triphosphate moiety; RNA molecules 
synthesized by the host are modified to remove this key molecular signature. Host-derived proteins 
can also constitute non-self if the proteins encode non-host sequences, folds or activities such as 
virulence factors. Proteins that are modified by microbes or the host itself as a result of infection 
can create molecular signatures, unique to stressful events. Lastly, mislocalization of native 
chemicals is also a signature of non-self. Genomic, host DNA can escape the nucleus and 
mitochondria as a result of DNA damage or infection, which triggers PRRs to initiate inflammatory 
responses.  Of the many stress signatures, nonself nucleic acids are arguably the trickiest to sense, 
given the abundance of host nucleic acids in the cell.  
 
The immunostimulatory nature of nucleic acids 
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The primary role of DNA is to store genetic information, while RNA is generally considered to be 
a conduit for translating the genetic code into protein. DNA is typically double-stranded and 
restricted to the nucleus and mitochondria, while RNA is present in the nucleus and cytosol as 
single-stranded segments. Despite their ubiquitous presence and conserved roles in information 
storage and propagation, DNA and RNA have long been known to stimulate the immune system 
when introduced into eukaryotic cells (Stetson and Medzhitov 2006; Yan and Chen 2012; Gantier 
and Williams 2007).  Forced entry of dsDNA and dsRNA into mammalian cells results in a burst 
of pro-inflammatory molecules, including type-I interferons, the primary drivers of antiviral 
immunity. Considerable progress has been made to not only determine which proteins are involved 
in this innate immune response, but also what molecular signatures each sensor detects.  
 
Sources of cytosolic dsDNA  
Cytosolic dsDNA is an obvious danger signal. Viruses, microbes and tumor cells are the primary 
source of exogenous dsDNA (Xu et al. 2017; Ablasser and Gulen 2016). The cell’s own dsDNA 
can also be a source of danger signal. While the cell is careful to sequester dsDNA within the 
nucleus and mitochondria to keep it protected and localized, DNA damage (Hartlova et al. 2015), 
genome instability (Mackenzie et al. 2017; Harding et al. 2017), and organelle failure (West et al. 
2015; Yuan et al. 2017) can introduce host dsDNA into the cytosol.  
 
Regulatory strategies used by cytosolic dsDNA sensors 
Stress sensor activation is regulated primarily by two main processes: templated-oligomerization 
and/or allosteric regulation of enzymatic activity. The two main classes of cytosolic dsDNA 




Aim2-like receptors, ALRs. Prototypical ALR family members are composed of an N-terminal 
pyrin death domain (PYD), a central linker, and a C-terminal HIN domain(s) (HIN: hematopoietic 
interferon-inducible nuclear protein with a 200 amino acid repeat). Activation is achieved by 
dsDNA-templated oligomerization. The HIN domains associate with dsDNA in a sequence-
independent manner. Proximal binding of multiple ALRs increases the probability of PYD ring 
formation (nucleation) and subsequent oligomerization (Morrone et al. 2015; Matyszewski, 
Morrone, and Sohn 2018). The PYD oligomer then seeds oligomerization of the downstream 
signaling adaptor protein (Fernandes-Alnemri et al. 2009; Hornung et al. 2009). This strategy 
creates a filtering mechanism dictated by dsDNA length that can be demonstrated both in vitro and 
in cells. dsDNA length-dependence ensures that ALR activation is only achieved under conditions 
of stress, such as during viral or microbial infection which can coincide with the presence of long 
genomic dsDNA.   
 
Cyclic GMP-AMP synthase, cGAS. cGAS is a nucleotidyl transferase (NTase) that couples ligand 
binding to catalytic activity (Sun et al. 2013). Upon dsDNA binding, cGAS produces a cyclic 
dinucleotide, cyclic GMP-AMP (GAMP), from ATP and GTP, which serves as a second 
messenger in its stress signaling pathway. cGAMP is unique from the products of other NTases, 
like polymerases and oligoadenylate synthase (OAS), in that it is cyclized and has mixed 
phosphodiester linkages, 2’-GMP-5’-AMP and 3’-AMP-5’-GMP (Ablasser et al. 2013; Diner et 
al. 2013; Zhang et al. 2013). cGAS activity also relies on templated, self-association, although the 
mechanism for how this contributes to self vs nonself discrimination has evolved considerably 




Allostery and dsDNA length-dependent activation of cGAS 
Regulation of cGAS enzymatic activity at the individual protein level is shared between cGAS and 
its close, dsRNA sensing relative, OAS; double-stranded nucleic acids allosterically promote 
conformational changes that stabilize the active, catalytic state. Multiple, atomic-resolution 
structures of cGAS revealed how dsDNA potentiates catalysis. Key conformational changes are 
observed upon dsDNA binding. At the dsDNA binding site, the so-called “spine helix” alters is 
structure, resulting in an elongated, contiguous helix. dsDNA binding also appears to force a short 
stretch of amino acids near the active site, the activation loop, to become ordered as a mean to 
reduce steric clash with the bound dsDNA. Both conformational changes are responsible for 
properly orienting acidic residues within the active site that align divalent cations for the catalysis 
of nucleotidyl transfer (Kato et al. 2013; Civril et al. 2013; Kranzusch et al. 2013; Shu, Li, and Li 
2014; Zhou et al. 2018).  
 
Although, in principle, monomeric cGAS should be sufficient for dsDNA-induced activity, self-
association is critical for cGAS activity. Evidence for this first came from crystal structures of 
cGAS. Of the 38 structures solved of mouse, pig and human cGAS, all have captured cGAS in the 
dimeric state, regardless of bound ligands. Importantly, this was far from crystallographic artifact. 
Mutational studies showed that dsDNA binding affinity and activity were severely compromised 
if dimerization was impeded, and that the cGAS-mediated immune response was virtually 
incapacitated for dimerization-null mutants (Li et al. 2013; Zhang et al. 2014). Again, structures 
of cGAS bound to dsDNA hinted at the reason. cGAS forms a 2:2 complex with short dsDNA (2 
cGAS molecules per 2 molecules of dsDNA) within the crystal lattice. Biophysical 
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characterization of mouse cGAS in solution determined that mouse cGAS has minimal auto-
dimerization capacity (Kdimer >> 100M), but dsDNA can drive dimerization in a dsDNA length- 
and sequence-independent manner, providing the causal link between cGAS dimerization and 
activity.  
 
However, recent literature contests the idea that dsDNA length is not important for cGAS 
signaling. Two, independent groups discovered that cGAS activity is dsDNA length-dependent in 
cells and in vitro (Andreeva et al. 2017; Luecke et al. 2017b). A structure of mouse cGAS bound 
to longer dsDNA (39 base-pair) indicated that cGAS dimers could propagate along parallel 
duplexes like rungs on a ladder (Andreeva et al. 2017). The authors provided evidence to suggest 
that dsDNA length dictated the probability of cGAS dimerization and ladder formation. The 
implications of this were that cGAS (functional) binding affinity would be cooperative and dsDNA 
length-dependent, which the authors showed by ITC and a new activity assay. Moreover, because 
dimerization was known to be required for activity, laddering could explain why dsDNA length 
correlated with cGAS activity. Although the model revealed important relationships between 
dsDNA length, binding affinity and cGAS activity, it fell short of accurately explaining how 
dsDNA length-dependence could be context specific. A more-sound, biophysical and biochemical 
approach would be required to better understand the allosteric nature of cGAS activation (see 
chapter 3).  
 
Pleiotropic outcomes from cGAS activation  
In 2013, cyclic GMP-AMP synthase (cGAS) was identified to be the major initiator of anti-viral 
and pro-inflammatory signaling in response to cytosolic DNA (Sun et al. 2013). This, and multiple 
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studies thereafter, led to the aggregate conclusion that cGAS plays an essential, protective role 
during infection by DNA viruses, some RNA viruses, and many species of bacteria (Watson et al. 
2015; Collins et al. 2015; Gao, Wu, et al. 2013; Hansen et al. 2014; Lam and Falck-Pedersen 2014). 
Subsequent studies also identified that cGAS contributes to stress responses spurred by DNA 
damage (Li and Chen 2018), missegregation of chromosomal DNA during cell division 
(Mackenzie et al. 2017; Harding et al. 2017), and mitochondrial malfunction (West et al. 2015; 
Sun et al. 2017; West and Shadel 2017). Thus, cGAS signaling broadly impacts numerous cellular 
processes. 
 
Conventionally, cGAS signals through stimulator of interferon genes (STING), a resident ER 
transmembrane protein (Ablasser et al. 2013; Diner et al. 2013; Zhang et al. 2013). cGAMP 
binding to STING promotes conformational changes within the dimeric, cytosol-facing domain, 
enacting the recruitment of kinases and other factors that lead to transcriptional activation and 
synthesis of pro-inflammatory molecules including chemokines and type-I interferons (IFN-I) via 
transcription factors interferon regulatory factor 3 (IRF3) and NFB (Abe et al. 2013; Stetson and 
Medzhitov 2006; van Boxel-Dezaire, Rani, and Stark 2006; Ishikawa, Ma, and Barber 2009). IFN-
Is are potent inducers of the anti-viral stress response and signal in an autocrine and paracrine 
fashion. Chemokines recruit immune cells to the site of cellular stress. The immune cells mitigate 
the spread of stress to other cells and prime T- and B-cells of the adaptive immune system for 
activation. This link between innate immunity (cGAS/STING) and adaptive immunity (T-cell 
activation) is of considerable importance. A hallmark of cancer cells is increased genomic 
instability and DNA damage. These processes produce cytosolic dsDNA that cGAS can detect 
(Zhang et al. 2015; Li et al. 2016; Mackenzie et al. 2017; Wang, Hu, et al. 2017; Li and Chen 
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2018). However, some tumors down-regulate cGAS signaling (Wu et al. 2017), which is thought 
to enable these malignant cells to avoid detection by mature immune cells.   
 
Although cGAS activity is intrinsically controlled by dsDNA length, the consequence of its 
signaling can vary dramatically. This is in part due to the pleiotropic effects of IRF3/NFB 
activation and IFN-I signaling. Unlike the dsDNA sensing pathway of AIM2 which results in 
interleukin production and pyroptotic cell death (Fernandes-Alnemri et al. 2009; Hornung et al. 
2009), a binary process, cGAS signaling can lead to outcomes that vary from autophagy (Watson 
et al. 2015; Prabakaran et al. 2018; Lei et al. 2018), anti-viral states (Sun et al. 2013), senescence 
(Gluck et al. 2017; Yang et al. 2017; Li and Chen 2018) and cell death (Gulen et al. 2017; Gaidt 
et al. 2017; Brault et al. 2018). The cellular response is correlated with cell-type, and the amount 
and time-for-which cGAMP presides in the cell (Gulen et al. 2017). Hence, prolonged activity due 
to slow clearance of dsDNA (Ablasser et al. 2014; Gregg, Sarkar, and Shoemaker 2018), 
inadequate degradation of cGAMP (Li et al. 2014), or lack of feedback regulation on cGAS or 
STING can dramatically affect the outcome of stress (Chen, Sun, and Chen 2016; Luo and Shu 
2018). The implications of this are best exemplified by auto-immune diseases, whereby sustained 
levels of pro-inflammatory molecules hyper-sensitize the innate and adaptive immune system, 
leading to dysregulated activity of the host’s immune system against its own tissues (Ablasser and 
Gulen 2016; Li, Wilson, and Kiss-Toth 2017).  
 
The goal of this thesis work was to establish a unifying allosteric activation model for cGAS. The 
model should describe how dsDNA length dictates cGAS activity levels, why dsDNA length-
dependence can vary with reaction context, and how cGAS signaling is attenuated. The model 
10 
 
should also provide a robust framework for testing and understanding how extrinsic factors such 
as post-translational modifications, metals, co-sensors, inhibitors and other nucleic acids affect 
cGAS activity. Lastly, the model should inform observations made from cells and organisms and 
make predictions about how cGAS activity contributes to cell fate decisions and disease. 
 
The project began with, and would not have been possible without, the implementation of a novel 
cGAS activity assay that monitors the production of byproduct during cGAS catalysis (Chapter 2). 
Using this activity assay, in tandem with numerous biophysical techniques, I revealed the coupled 
relationships between cGAS activity, its oligomeric state and its allosteric regulators, ATP/GTP 
and dsDNA (Chapter 3). Using the allosteric model as a guide, I began to unravel the unique and 
surprising ways in which manganese affects cGAS activity (Chapter 4). Findings from this work 
contribute broadly to our understanding of allostery, enzyme-mediated catalysis, protein self-
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Cyclic GMP-AMP synthase (cGAS), a pattern recognition receptor of the innate immune system, 
induces the expression of type-I interferon (IFN-I) genes by binding cytosolic double-stranded 
(ds)DNA and synthesizing the unique second messenger, cyclic GMP-AMP (cGAMP), from ATP 
and GTP (Sun et al. 2013). cGAMP binds and activates stimulator of interferon genes (STING) 
(Ablasser et al. 2013; Zhang et al. 2013; Gao, Ascano, et al. 2013), which recruits and activates 
Tank-binding kinase 1 (TBK1) leading to activation of transcription factors, IRF3 and NF- B 
(Ishikawa, Ma, and Barber 2009). The IFN-I response has variable outcomes and depends heavily 
on the strength of cGAS signaling (Vanpouille-Box et al. 2018; Li and Chen 2018; Gulen et al. 
2017). Hence, knowing how cGAS activity is regulated at the molecular level, has the potential to 
inform observations made at the cell, tissue and organism level.  
 
Numerous methods have been developed to track cGAS activity (Bose et al. 2016; Vincent et al. 
2017; Hall, Brault, et al. 2017; Wang, Sooreshjani, et al. 2018; Ablasser et al. 2013; Liu et al. 
2017; Andreeva et al. 2017). Most methods rely on the ability to directly measure cGAMP, the 
biological signaling molecule. However, in theory, an equally reliable proxy for nucleotidyl 
transferase (NTase) activity is the production of pyrophosphate, the by-product of cGAMP 
synthesis. Indeed, pyrophosphate detection has been employed to study numerous systems 
including NTases (Lloyd et al. 1995; Chang et al. 1984; Cestari and Stuart 2013; Seamon and 
Stivers 2015; Yi et al. 2011; McMillan, Hepowit, and Maupin-Furlow 2016). Pyrophosphate, 
itself, is seldom measured directly, rather its degradation product, inorganic phosphate, is 
quantified. Pyrophosphate is relatively stable under physiological conditions, but its degradation 
into inorganic phosphate is accelerated under low pH, by divalent cations and/or by enzymes that 
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specifically catalyze the hydrolysis of pyrophosphates, e.g. pyrophosphatases (Stockbridge and 
Wolfenden 2011). Enzyme-mediated hydrolysis of pyrophosphate is far superior to chemical 
alternatives as evidenced by the 106-fold faster hydrolysis rate produced by pyrophosphatases. The 
high efficiency of pyrophosphatases is particularly critical for ensuring accurate rate measurement 
of target enzymes.  
 
The specific measurement of cGAS NTase activity employs the coupled hydrolysis of 
pyrophosphate by E. coli pyrophosphatase (Figure 1A). Reactions are quenched with divalent 
cation chelators, such as EDTA, and the phosphate concentration is determined colorimetrically 
by measuring the absorbance of malachite green- phosphomolybdate complexes (Baykov, 
Evtushenko, and Avaeva 1988). Absolute values of phosphate are determined by comparing 
enzyme reactions to an internal, inorganic phosphate standard curve. This strategy has multiple 
advantages over direct detection of cGAMP. Phosphate detection is relatively cheap and relies 
mainly on a plate reader equipped with a UV-vis detector. The assay is also essentially label-free, 
which relieves restrictions on substrate concentration and substrate identity, and is scalable for 
high-throughput applications (Cestari and Stuart 2013; Seamon and Stivers 2015). Importantly, 
the assay lends itself to conventional steady-state enzymatic measurements with minimal 
hindrances, enabling accurate and rigorous measurement of cGAS enzymatic properties. Lastly, 
given the relatively slow turnover of cGAS (Vincent et al. 2017; Zhou et al. 2018), phosphate 
detection provides the benefit of immediate signal amplification per turnover event due to two 




This chapter details how to successfully implement the PPiase-coupled NTase activity assay for 










E. coli pyrophosphatase 
 
Lysis Buffer - 25mM Tris HCl pH 7.5, 1mM DTT, 5% glycerol, 500mM NaCl, PMSF, lysozyme, 
benzamidine, DNaseI 
Wash Buffer - 25mM Tris HCl pH 7.5, 1mM DTT, 5% glycerol, 500mM NaCl 
Amylose Elution Buffer - 25mM Tris HCl pH 7.5, 1mM DTT, 5% glycerol, 500mM NaCl, 10mM 
maltose 
TEV Dialysis Buffer - 25mM Tris HCl pH 7.5, 125mM NaCl, 10mM -ME 
Heparin Buffer - 25mM Tris HCl pH 7.5, 1mM DTT, 5% glycerol, 300mM NaCl 
Gel filtration buffer - 25mM Tris HCl pH 7.5, 1mM DTT, 5% glycerol, 300mM NaCl 
Storage Buffer - 25mM Tris HCl pH 7.5, 1mM DTT, 20% glycerol, 300mM NaCl 
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Reaction Buffer – 25mM Tris Acetate pH 7.4, 125mM potassium acetate pH 7.4, 0.5mM Tcep pH 
7.4, 5mM magnesium chloride, 5% glycerol 
2x Quench Buffer - 25mM Tris Acetate pH 7.4, 125mM potassium acetate pH 7.4, 0.5mM Tcep 




Hydrate ATP and GTP separately in deionized water (ddH20) supplemented with 20mM HEPES 
buffer pH 7.4. Target concentrations are 100mM for ATP and 50mM for GTP. Adjust the pH to 
~7-8 using concentrated sodium hydroxide. It is best to do this quickly to avoid hydrolysis of either 
NTP. Measure the concentration of each nucleotide spectrophotometrically. max (ATP) = 259nm, 
 = 15,400 M-1 cm-1; max (GTP) = 252nm,  = 13,700 M
-1 cm-1.  
 
Optional: Divalent metal cations can be added to the nucleotide stocks but should be done so prior 
to pH adjustment. Metals are typically equimolar or in 10% molar excess.   
 
Preparation of recombinant cGAS 
This protocol is adapted from (Kranzusch et al. 2013). Clone the full-length, human cGAS 
sequence into a pET28b vector (Novagen) in-frame with an N-terminal 6xHis-MBP-tag and a TEV 
protease cleavage site. Transform E. coli BL21 Rosetta 2 cells with the plasmid and plate on agar 
supplemented with Kanamycin and Chloramphenicol. Inoculate a starter culture supplemented 
with antibiotics with a single clone and grow overnight at 37°C. Inoculate Luria Broth media 
supplemented with antibiotics with 1:100 overnight culture and grow at 37°C until an OD600 of 
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0.6-0.8.  Chill the culture at 4°C for 90 minutes prior to adding 200 µM IPTG. Grow the cells at 
16°C overnight. Pellet the cells and store at -80°C. For protein purification, resuspend cells in lysis 
buffer and lyse by sonication. Clarify the lysate by centrifugation. Apply the clarified lysate to 
amylose resin, and wash with 4CV of Wash Buffer before eluting with Amylose Elution Buffer. 
Add TEV protease to the eluted fractions and dialyze overnight at 4°C in TEV Dialysis Buffer. 
Adjust the dialysate to 5% glycerol and 300mM NaCl.  Apply the dialysate to heparin resin (GE 
Healthcare), and wash with Heparin Wash Buffer. Flash elute the protein in Heparin Wash Buffer 
supplemented to 800mM NaCl. Apply the eluted fractions to a Superdex 200 16/60 (cGASFL) in 
Gel Filtration Buffer. Combine the monomer and dimer peaks and apply to amylose resin to 
remove residual, uncleaved protein. Adjust the flow through to 20% glycerol and concentrate the 
protein to 50uM. Aliquot, freeze and store the protein at -80°C  
 
Malachite Green Solution (MGS) 
0.4 grams of malachite green, 300mls ddH20, 60mls of concentrated sulfuric acid.  
 
Color Development Solution 
200l 7.5% (w/v) sodium molybdate (ddH20), 16l Triton x-100, 800l MGS 
 
Phosphate Stock 
Hydrate sodium phosphate monobasic in ddH20. Calibrate the phosphate concentration using a 
commercial stock of aqueous phosphate and the protocol described here for quantifying phosphate. 
 
Preparation of E. coli pyrophosphatase 
22 
 
See (Seamon and Stivers 2015) for full details.  
 
Method 
1. Prepare a 10x stock of nucleotides. Combine reaction buffer, ATP, GTP and 2 molar equivalents 
of divalent cation. Metal stocks are typically 1-2M. Mix thoroughly. Note: Additional metal is 
only required if the nucleotide stocks were not hydrated with metal.  
2. Reaction set-up. Combine reaction buffer, 10-200nM PPiase, cGAS
FL and dsDNA to cGAS 
reaction tubes. Repeat this for control reactions but substitute cGAS with reaction buffer. Add 10x 
nucleotide(s) to initiate the reaction. Note: The reaction series should be time-matched. Start a 
timer and initiate a new reaction with nucleotides every 10-15 seconds.  
3. Quenching. Add 20l of 2x Quench Buffer to the appropriate number of wells on the 384-well 
assay plate. For each time point, remove 20l of each reaction and add it to the appropriate well. 
Use the same interval from Step 2 to ensure each reaction runs for the same time. 
4. Phosphate standards. In the assay plate, prepare 20l volumes of 90uM, 60uM, 30uM and 15uM 
inorganic phosphate diluted in reaction buffer. Add 20l of 2x Quench Buffer to each.  
5. Color development. Prepare the Color Development Solution when all time points have been 
collected. Add 10l of Color Development Solution to each well. Set the plate on a nutating shaker 
at room temperature.  
6. Scan the absorbance of each well between 610nm and 650nm in 2nm steps. Calculate the 
maximum absorbance value for each well. Using the slope of phosphate standard curve, determine 
the concentration of phosphate in each well. Subtract the phosphate concentration of control 
reactions from the corresponding cGAS reaction. Calculate the rate of phosphate production by 
fitting the phosphate concentration over time to a line. Divide this number by two to account for 
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each pyrophosphate produced. Normalize the reactions by the concentration of cGASFL to obtain 
apparent rates of PPi production min
-1 cGAS-1.  
 
Notes:  
1. Conceptually, any homolog of pyrophosphatase can be used in this assay. However, not all 
homologs share the same catalytic efficiency towards pyrophosphate and may exude differences 
in activity depending on buffer composition, especially with respect to divalent cation identity and 
concentration (Kunitz 1962; Zyryanov, Lahti, and Baykov 2005; Halonen et al. 2002). E. coli 
pyrophosphatase is an efficient enzyme under the conditions used here and is simple to purify; 
high yields of commercial-grade enzyme can be purified from E. coli without a chromatographic 
purification step (Seamon and Stivers 2015). Hence, it was deemed suitable for this purpose.  
2. The concentration of pyrophosphatase in the reaction is dictated by the rate of PPi production 
by the target enzyme. Ensure PPiase is not rate-limiting by measuring catalytic rates of PPi 
hydrolysis under the desired reaction conditions (Figure 1B). The rate of PPi hydrolysis should be 
>> faster than the rate of PPi production by the target enzyme.  
3. The main disadvantage of this assay is its discontinuous nature. This makes kinetic 
measurements rather tedious. One alternative strategy is to combine this PPiase-coupled assay with 
the real-time, spectrophotometric assay that couples the conversion of MesG (max=330nm) and 
inorganic phosphate to the free base moiety (max=360nm) and 1-phosphate-ribose via the enzyme, 
PNP (Upson et al. 1996; Lloyd et al. 1995). Appropriate considerations should be made to ensure 
the additional coupling enzymes and reagents do not interfere with cGAS or PPiase, and that the 
coupling step is not rate-limiting.  
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4. This assay is amenable for both 96-well and 384-well formats. High-throughput applications, 
e.g. small-molecule discovery efforts, are feasible with the assay described here (Cestari and Stuart 
2013; Seamon and Stivers 2015; Zhang, Chung, and Oldenburg 1999). Z’ values for the 96-well 
and 384-well will vary heavily on the selected conditions, including substrate concentration, DNA 







Figure 1.  
A) Scheme of the pyrophosphatase-coupled activity assay.  
B) Raw sample data of E. coli pyrophosphatase steady-state turnover of inorganic pyrophosphate 
in the presence of different concentrations of free divalent metal. Each reaction contained 80M 
pyrophosphate pre-mixed with one molar equivalent of Mn2+ (pink and red) or Mg2+ (dark and 
light blue). 
C) Raw sample data of cGAS (125nM) steady state activity in the presence of different substrates 
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Whether arising endogenously or exogenously, double-stranded (ds)DNA in the cytoplasm of 
eukaryote cells indicates major problems (Chen, Sun, and Chen 2016; Paludan and Bowie 2013). 
For instance, genomic instability and damaged mitochondria introduce dsDNA into the cytoplasm 
(Chen, Sun, and Chen 2016; Denais et al. 2016; Paludan and Bowie 2013; West and Shadel 2017; 
Shen et al. 2015; Mackenzie et al. 2017), and nearby rampant necrosis or pyroptosis can lead 
dsDNA to the cytoplasm of neighboring cells (Abe et al. 2013; Ishii et al. 2001). Moreover, the 
invasion of pathogenic bacteria or viruses introduces foreign dsDNA into the host cytoplasm 
(Chen, Sun, and Chen 2016; Paludan and Bowie 2013).  
 
In metazoans, cyclic GMP-AMP synthase (cGAS) plays a predominant role in initiating host 
innate immune responses against cytoplasmic dsDNA (Chen, Sun, and Chen 2016). Upon 
detecting cytoplasmic dsDNA, cGAS cyclizes ATP and GTP into [2’-5’, 3’-5’]-linked cGAMP 
(Gao, Ascano, et al. 2013), a unique host second-messenger for activating type-1 mediated stress-
responses via Stimulator of Interferon Genes (STING). cGAS is integral not only to the host 
defense against all pathogens entailing DNA for replication (e.g. HIV, HSV, L. monocytogenes; 
(Hansen et al. 2014; Reinert et al. 2016; Gao, Wu, et al. 2013), but also to damaged organelles  
(West et al. 2015; Mackenzie et al. 2017). Moreover, cGAS plays a major role in regulating 
autoimmunity (e.g. Aicardi-Goutières syndrome and systemic lupus erythematosus (Pokatayev et 
al. 2016; Vincent et al. 2017; An et al. 2017; Gao et al. 2015)) and tumor formation and growth 




A signature of IFN-1 signaling is its variable outcomes, which include antiviral gene expression, 
cellular senescence, autophagy, and apoptosis (van Boxel-Dezaire, Rani, and Stark 2006; Li and 
Chen 2018; Liang et al. 2014; Li et al. 2016; Sun et al. 2013; Yang et al. 2017). cGAS contributes 
significantly to this complex signaling landscape, with its signal strength, signaling duration, and 
cellular contexts influencing the type of outcomes (Li and Chen 2018). For example, the outcome 
of the cGAS pathway depends on cell type (e.g. non-apoptotic macrophages vs. apoptotic T-cells 
(Gulen et al. 2017; Li et al. 2016; Tang et al. 2016; Larkin et al. 2017)), the amount of cGAMP 
(e.g. autophagy vs. apoptosis (Liang et al. 2014; Li et al. 2016; Tang et al. 2016; Gulen et al. 
2017)), and the duration for which cells are stimulated with cGAMP (antiviral gene expression vs. 
apoptosis (Li et al. 2016; Tang et al. 2016; Gulen et al. 2017; Larkin et al. 2017)). The goal of the 
present study is to understand the molecular mechanisms by which cGAS drives such a dynamic 
signaling landscape. 
 
Resting cGAS is thought to be an inactive monomer, and formation of a 2:2 dimer with dsDNA 
within the catalytic domain (human cGAS residue 157-522) is necessary for activation (2 cGAS 
molecules on 2 dsDNA duplexes (Li et al. 2013; Zhang et al. 2014)). cGAS recognizes dsDNA 
independent of sequence (Gao, Ascano, et al. 2013; Kranzusch et al. 2013; Li et al. 2013; Zhang 
et al. 2014), and it was initially proposed that any dsDNA long enough to support cGAS 
dimerization could activate the enzyme equally well (e.g. ~15 base-pairs, bps (Li et al. 2013; Zhang 
et al. 2014; Chen, Sun, and Chen 2016)). However, it was long known that dsDNA of at least 45 
bp was required to elicit IFN-1 responses in cells (Stetson and Medzhitov 2006; Unterholzner et 
al. 2010; Chen, Sun, and Chen 2016). Indeed, two recent studies demonstrated that cGAS 
discriminates against short dsDNA (Andreeva et al. 2017; Luecke et al. 2017b). For instance, 
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cGAS is minimally activated in cells by dsDNA shorter than 50 bps, and maximal activation 
requires dsDNA longer than 200 bps, with the length-dependence more pronounced at lower 
dsDNA concentrations (Andreeva et al. 2017; Luecke et al. 2017b). The dependence on dsDNA 
length is thought to arise because cGAS dimers linearly propagate along the length of two parallel 
dsDNA strands without making inter-dimer contacts, consequently generating a ladder-like 
complex that increases the overall stability via avidity (Andreeva et al. 2017). Together, it is 
believed that dsDNA length-based signal-to-noise filtration occurs at the binding/recognition stage 
(i.e. different KDs for different dsDNA lengths), but not at the signal transduction step (i.e. same 
Vmax for different dsDNA lengths  (Andreeva et al. 2017)).  
 
Our understanding of the mechanisms by which cGAS is activated has evolved over the years, yet 
it remains unclear why two conflicting views on the role of dsDNA length have existed. Moreover, 
we noted that neither the previous (dsDNA length-independent) nor current (dsDNA length-
dependent) activation model provides a robust framework for understanding how cGAS might be 
able to shape its diverse signaling landscape. First, the relationship between dsDNA binding and 
activation is poorly established. For instance, it remains to be tested whether the initial dsDNA 
recognition step alone sufficiently explains the dsDNA length-dependent activation of cGAS in 
cells.  Second, the ladder model implies that dimerization efficiency continuously increases with 
dsDNA lengths (> 1000 bps), while the optimal cellular response peaks with any dsDNA longer 
than ~200 bps (Andreeva et al., 2017).  Third, the ladder model is heavily based on structural and 
functional studies of the catalytic domain of cGAS (cGAScat). It was recently proposed that the N-
domain of cGAS binds dsDNA and plays a crucial role in its cellular function (Tao et al. 2017; 
Wang, Ning, et al. 2017). Moreover, dsDNA binding by the N-domain is thought to enhance the 
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activity of the monomeric enzyme, consequently lifting the dsDNA length restriction (Lee et al. 
2017). Thus, it is not clear whether the ladder-like arrangement applies exclusively to cGAScat, or 
whether it is germane to the full-length protein (cGASFL). Finally, given that cGAS is the 
predominant sensor for cytoplasmic dsDNA (Chen, Sun, and Chen 2016), it is imperative for this 
enzyme to amplify and attenuate its signaling cascade in a switch-like manner to ensure proper 
host responses. How cGAS achieves this important task remains poorly understood.  
 
We find here that human cGAS can auto-dimerize without dsDNA. dsDNA regulates this intrinsic 
monomer-dimer equilibrium not only in a cooperative, but also in a length-dependent manner. 
Unexpectedly, substrates (ATP/GTP) can pull cGAS into the dimeric state without dsDNA. 
Because ligand binding is coupled to dimerization, the length of dsDNA not only regulates binding 
and dimerization (signal recognition), but also the substrate binding and catalysis (signal 
transduction). Compared to cGAScat, cGASFL auto-dimerizes more readily and also couples 
binding of both substrate and dsDNA to dimerization more efficiently, revealing a new function 
of the N-domain in potentiating the dimerization of cGAS. Dimerization is essential for dsDNA-
mediated activation of both cGASFL and cGAScat, and the dimers do not arrange in an ordered 
configuration on long dsDNA, suggesting the role of dsDNA length is to simply regulate the 
probability of dimerization. Importantly, shifting the monomer-dimer equilibrium via elevated 
enzyme and ATP/GTP concentrations in the absence of dsDNA does not override the requirement 
for dsDNA to activate cGAS. Instead, these other factors prime the enzyme to be activated even 
by short dsDNA, indicating that the dependence on duplex length can change according to cellular 
reaction context. Together, our results set forth a unifying activation model for cGAS in which the 
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intrinsic monomer-dimer equilibrium poises the enzyme to dynamically turn its signaling pathway 
on or off in a switch-like fashion. 
 
Results 
Human cGAScat can dimerize without dsDNA 
Human cGAScat (denoted as cGAScat hereafter) eluted as two peaks in size-exclusion 
chromatography (SEC) depending on protein concentration (Figure 1A). With decreasing protein 
concentrations, the two peaks progressively merged into the one with the lower apparent 
hydrodynamic radius (Figure 1A), suggesting that cGAScat is subject to an intrinsic monomer-
dimer equilibrium without dsDNA (Figure 1-figure supplement 1). This was surprising, as 
previous studies showed that mouse cGAScat behaved as a monomer (Li et al. 2013); we speculate 
that mouse-cGAScat intrinsically dimerizes more weakly.  
 
To further test the intrinsic dimerization capability of cGAS, we examined the oligomeric state 
using small-angle x-ray scattering (SAXS). SAXS revealed that the radius of gyration (Rg) and 
maximum diameter (Dmax) for apo- cGAS
cat at all tested concentrations aligned better with those 
of dsDNA-bound mouse-cGAScat dimer (Figures 1C-D; (Li et al. 2013)). We analyzed the 
distrbution of monomeric and dimeric species using SAXS-estimated molecular weight (SAXS 
MoW2 ) and OLIGOMER in ATSAS (Figure 1D (Petoukhov and Svergun 2013; Petoukhov et al. 
2012; Mylonas and Svergun 2007)). Here, the fraction of dimeric species was proportional to 
protein concentration, and the dimerization constant was estimated to be ~20 µM (Figure 1D). 
Together, we concluded that cGAS has an intrinsic, albeit weak, capacity to dimerize in the 




Figure 1. human wild-type cGAScat can dimerize on its own 
(A) SEC (Superdex 200 16/600) profile of cGAScat. 
(B) SAXS scattering profile of cGAScat.  
(C) Pair-wise distance distribution functions of cGAScat. Theoretical P(r)s from mouse-cGAScat 
are shown for comparison (PDB ID: 4lez). 




(Figure 1 figure supplement 1) Uv-vis absorbance profile of purified cGAScat. The predominant 





cGAS behaves like a classic allosteric enzyme 
In allosteric signaling enzymes, incoming signal (activator) and substrates either exclusively or 
preferentially bind to the active state and stabilize the corresponding conformation (Monod, 
Wyman, and Changeux 1965; Sohn, Grant, and Sauer 2007; Sohn and Sauer 2009; Koshland, 
Nemethy, and Filmer 1966). Such a coupling mechanism synchronizes conformational states with 
activity states, thereby allowing the enzymes to generate switch-like responses (Monod, Wyman, 
and Changeux 1965; Sohn, Grant, and Sauer 2007; Sohn and Sauer 2009; Koshland, Nemethy, 
and Filmer 1966). Importantly, preferential, but not exclusive ligand binding to the active state 
grades signaling output, as the distribution of active and inactive species is dictated by the relative 
binding affinity of different activators to either state (Sohn and Sauer 2009; Tsai and Nussinov 
2014; Monod, Wyman, and Changeux 1965). Our observation that cGAS can dimerize on its own 
suggests a new framework for understanding its activation mechanism (Figure 2A). Here, apo-
cGAS is placed in an intrinsic allosteric equilibrium where it is predominantly an inactive 
monomer under resting conditions. Overexpression (Ma et al. 2015), substrate binding, and 
cytoplasmic dsDNA synergistically activate cGAS by promoting dimerization. Furthermore, given 
that monomeric cGAS binds dsDNA (Andreeva et al. 2017; Li et al. 2013), it is possible that 
dsDNA length determines the fraction of active dimers (Figures 2B), thus underpinning the duplex 
length dependent cellular activity (Andreeva et al. 2017; Luecke et al. 2017b). Below, we describe 
a series of experiments to further test and develop this allosteric framework for understanding the 
activation of cGAS. 
 
The cellular activity of cGAS is dsDNA length-dependent (Andreeva et al. 2017; Luecke et al. 
2017b), as if the enzyme uses duplex length as a ruler to differentiate between signal and noise. 
39 
 
Currently, it is believed that this length-based noise filtration occurs only at the initial encounter 
step, with longer dsDNA invoking a ladder-like arrangement (Andreeva et al. 2017). However, all 
previous binding studies entailed raising cGAS concentration (Andreeva et al. 2017; Li et al. 
2013), which intrinsically alters the dimer population. Thus, we re-examined the coupled 
relationship between dsDNA-binding and dimerization without altering the intrinsic dimerization 
equilibrium. First, using both direct and competition methods, we observed that cGAScat indeed 
binds dsDNA in a length-dependent manner (Figure 2-figure supplement 1A-B). Next, to directly 
monitor dimerization, we conjugated a FRET donor and acceptor peptide to two populations of 
cGAScat via sortaseA (FRET: Förster Resonance Energy Transfer; Figure 2-figure supplement 1C). 
The dimerization of a 1:1 mixture of donor- and acceptor-labeled cGAScat at physiologically 
relevant concentrations was then tracked by changes in FRET emission ratios between the donor 
and acceptor with increasing concentrations of dsDNA (Figure 2-figure supplement 1C; 
physiological concentrations of cGAS vary ~10-500 nM (Andreeva et al. 2017; Ma et al. 2015; Du 
and Chen 2018b)). 
 
Increasing concentrations of 24-bp dsDNA did not induce significant changes in FRET ratios 
(Figure 2C), consistent with the previous report that such a short dsDNA binds cGAS but cannot 
induce dimerization (Andreeva et al. 2017). With longer dsDNA, we observed more robust 
changes in FRET signals (Figure 2C). Importantly, the half-maximal dsDNA concentrations 
necessary to induce the FRET signal (KFRET ) decreased with longer dsDNA, and the length 
dependence plateaued around ~ 300 bps (Figures 2C-D). The maximal change in FRET ratio also 
generally increased with longer dsDNA, suggesting the dimeric fraction increased with longer 
dsDNA (Figure 2C). The fitted Hill constants in these experiments were between 1.5 and 2, 
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indicating that dsDNA-induced dimerization is a cooperative process (Figure 2E). Overall, our 
results confirm that dsDNA binding and dimerization are directly coupled, consistent with the idea 
that the intrinsic monomer-dimer equilibrium underpins dsDNA length discrimination by cGAS 
(Figures 2A-B). 
 
It is thought that cGAS does not bind ATP/GTP in the absence of dsDNA, as the loops surrounding 
the active site would block substrate entry (Gao, Ascano, et al. 2013). However, cGAS can bind 
cGAMP in the absence of dsDNA, and multiple crystal structures indicate that the B-factors of 
loops surrounding the active site are 5- to 20-fold higher than the protein core, suggesting cGAS 
might be able to weakly interact with ATP/GTP even without dsDNA (e.g. PDB IDs: 4k8v, 4o69, 
and 4km5; (Gao, Ascano, et al. 2013; Kranzusch et al. 2013; Zhang et al. 2014)). Thus, we tested 
whether ATP/GTP and their nonhydrolyzable analogues (AMPcPP/GMPcPP) could induce 
dimerization. Here, substrates increased the FRET ratio, albeit to a lower extent than long dsDNA 
(Figure 2F), suggesting that substrates alone can pull cGAScat into the dimeric state to some degree. 
The lower capacity of AMPcPP/GMPcPP to induce FRET changes is consistent with our 
observations that the analogues bind more weakly than ATP/GTP (Ki = 280 µM (Figure 2-figure 
supplement 1D) vs. KM of ~100 for ATP/GTP with dsDNA, see Figure 3 below). Together, our 
results suggest that the fraction of active, dimeric cGAS would be partitioned according to the 
length of dsDNA and the availability of substrates (Figure 2A). Thus, our results support the notion 





Figure 2. dsDNA cooperatively induces the dimerization of cGAS in a length dependent 
manner 
(A) A scheme describing the allosteric framework of cGAS activation. Here, cGAS is subject to 
an intrinsic allosteric equilibrium with two major activity/conformational states, namely inactive 
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monomer and active dimer. Resting cGAS is predominantly an inactive monomer (top). dsDNA 
(length-dependent) binding, increasing cGAS concentration, and substrate binding synergistically 
drive the allosteric equilibrium toward the active dimer.  
(B) An allosteric model describing dsDNA length-dependent distribution of active dimers and 
inactive (basally active) monomers.  
(C) Changes in the ratio between FRET donor emission (λmax: 578 nm) and the acceptor emission 
(λmax: 678 nm) of labeled cGAS
cat (20 nM each) at indicated dsDNA concentrations.  
(D) A plot of dimerization efficiency (KFRET) vs. dsDNA length (n = 3; ± SD). 
(E) A plot of fitted Hill constants vs. dsDNA lengths (n = 3; ± SD). 
(F) Changes in the ratio between the FRET donor/acceptor emission ratios of labeled cGAScat (20 





(Figure 2 figure supplement 1A) Binding of cGAScat to each FAM-labeled dsDNA (5 nM) was 
determined by FA. The lines are fits to a standard binding isotherm. 
(Figure 2 figure supplement 1B) Competition binding assay using 72-bp FAM-dsDNA (5 nM) and 
cGAScat (80 nM; ~ KD
 for 72-bp FAM-dsDNA) against various unlabeled dsDNA lengths; the 
lines are fits to a competition binding equation: (1/(1+(dsDNAcompetitor)/IC50)
Hill constant ). 
Fraction bound was calculated based on the changes in fluorescence anisotropy (FA) of 72-bp 
FAM-dsDNA. 
(Figure 2 figure supplement 1C) Scheme for FRET-based dimerization assay. 
(Figure 2 figure supplement 1D) Competition activity assay using 339-bp dsDNA (4 µg/ml) and 
cGAScat (50 nM) and 150 µM ATP/GTP against increasing concentrations of AMPcPP/GMPcPP; 
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the lines are fits to a competition binding equation: (1/(1+(competitor)/IC50)
Hill constant ). The 
Reported Ki was calculated using the Cheng-Prusoff equation (Ki = IC50/([1+([S]/KM)]). 
 
A new quantitative assay for cGAS enzymatic activity 
All published methods that quantitatively monitor the enzymatic activity of cGAS track cGAMP 
production, and are not ideal for mechanistic studies because they are low throughput or make it 
difficult to saturate the enzyme with substrates (e.g. TLC, HPLC-Mass-Spec, and fluorescently-
labeled ATP/GTP; (Andreeva et al. 2017; Gao, Ascano, et al. 2013; Hall, Ralph, et al. 2017a; 
Vincent et al. 2017)). cGAS generates two inorganic pyrophosphates (PPi) per cGAMP. Thus, we 
adapted a pyrophosphatase (PPiase)-coupled assay to monitor cGAS activity (Figure 3A; (Seamon 
and Stivers 2015)). Using this assay, we found that cGAScat produces PPi most efficiently in the 
presence of a 1:1 mixture of ATP and GTP plus dsDNA (Figure 3B; > 90% of its NTase activity 
produces cGAMP when ATP and GTP are equimolar (Gao, Ascano, et al. 2013)). Moreover, no 
PPi production was observed from an inactive cGAS variant (E225A-D227A-cGAS
cat (Gao, 
Ascano, et al. 2013); Figure 3B), and the activity of PPiase was not rate-limiting (Figure 3-figure 
supplement 1). Thus, we concluded that the PPiase-coupled assay provides a robust method to 
quantitatively monitor the enzymatic activity of cGAS. 
 
dsDNA length regulates the extent of activation 
Our experiments thus far support an activation model in which dsDNA length determines the 
distribution between active dimers and inactive monomers (Figure 2A-B). This mechanism 
predicts that different dsDNA lengths would produce graded maximal signaling outputs (Vmax) 
even at saturating concentrations  of dsDNA (Sohn and Sauer 2009). In contrast, recent work 
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suggests that the dsDNA length-dependent activity of cGAS arises solely at the signal recognition 
step (binding), and not at the signal transduction step (enzymatic step; (Andreeva et al. 2017)). 
However, the authors did not conduct their studies under steady-state conditions due to their use 
of fluorescently-labeled substrates (Andreeva et al. 2017). Because our coupled-assay eliminates 
this issue, we directly tested whether dsDNA length could regulate the enzymatic activity of cGAS. 
Here, we found that cGAScat has low basal activity without dsDNA (180 ± 30 M-1min-1), which 
can be increased by 50-fold with > 300 bp dsDNA (Figure 3C). dsDNA concentrations required 
to induce the half-maximal activity of cGAScat increased with shorter dsDNA (Kact; Figure 3C and 
Figure 3-figure supplement 2A-B), consistent with the previously observed length-dependent 
binding ((Andreeva et al. 2017). Importantly, the maximum dsDNA-induced activity (kmax) also 
decreased with shorter dsDNA (Figures 3C and Figure 3-figure supplement 2A and 2C), which is 
in contrast to the previous report proposing that the role of dsDNA length is limited to binding 
(Andreeva et al. 2017).  Moreover, normalizing the kmax by Kact for each dsDNA length showed 
that the overall signaling efficiency of cGAScat (dsDNA binding and maximum output) changes 
more drastically compared to either parameter alone (Figure 3D, see also Figure 3- figure 
supplement 2A-C). For instance, the overall signaling efficiency changes by nearly 100-fold 
between 24 to 339 bp dsDNA, while either binding or maximal activity alone changes only up to 
10-fold (Figure 3D, see also Figure 3- figure supplement 2A-D). Together, our observations 
suggest that cGAS discriminates against short dsDNA not only at the initial recognition step, but 
again at the signal transduction step, resulting in two-stage dsDNA length discrimination. 
 
dsDNA length regulates formation of the enzyme-substrate complex (KM) and the turnover 
efficiency (kcat) of cGAS 
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We next determined substrate turnover kinetics in the presence of various dsDNA lengths. Without 
dsDNA, cGAScat showed slow, but measurable NTase activities (Figure 3- figure supplement 1B). 
With saturating dsDNA longer than 300 bps, the KM of cGAS
cat for ATP/GTP was near 100 µM, 
and the kcat was 5 min
-1 (Figures 3E and Figure 3-figure supplement 2D). The observed KM for 
ATP/GTP is comparable to previously reported values measured using Surface Plasmon 
Resonance (SPR) and rapid-fire Mass-Spec for both human and mouse enzymes (Hall, Ralph, et 
al. 2017a; Vincent et al. 2017). Moreover, the relatively slow kcat is consistent with a report 
indicating that human cGAS is considerably slower than mouse cGAS (~20 min-1) (Vincent et al. 
2017). Considering intracellular concentrations of ATP and GTP are > 1 mM and ~500 µM, 
respectively (Traut 1994; Chen, Freinkman, et al. 2016), our result suggests that once cGAS 
encounters cytoplasmic dsDNA, one cGAMP would be generated in less than 20 sec, compared to 
about one per 15 min in the absence of dsDNA. With shorter dsDNA, the KM increased about 2-
fold, and the kcat decreased up to 4-fold (Figures 3-figure supplement 3D). Combined, our results 
indicated that the overall catalytic efficiency of cGAS can change up to 8-fold (kcat/KM) by the 
length of bound dsDNA (Figure 3F and Figure 3-figure supplement 3D). On another note, the 
fitted Hill constants in these experiments were near two for all dsDNA lengths (Figure 3-figure 
supplement 2D), consistent with the observation from mouse cGAScat (Vincent et al. 2017). 
Because most cGAScat populations would be dimeric with saturating long dsDNA, the observed 
cooperativity is likely from substrate-substrate interactions (i.e. ATP binding enhances GTP 
binding or vice versa; (Vincent et al. 2017)). Overall, these results further support that dsDNA 




Figure 3. dsDNA length can grade the activity of cGAS 
(A) PPiase-coupled assay scheme.  
(B) A plot of time-dependent Pi production of cGAS




(C) A plot of the dsDNA concentration-dependent NTase activity of cGAScat (25 nM) and 1 mM 
ATP/GTP with various duplex lengths. Lines are fits to a Hill form of the Michaelis-Menten 
equation.  
(D) A plot of dsDNA-affinity normalized maximal activities of cGAScat vs. dsDNA lengths (n = 
3; ± SD). 
(E) Substrate dependence of the steady-state rate of NTase activity by cGAScat (125 nM) with 
saturating amounts of each dsDNA (6X Kact).  Lines are fits to a Hill form of the Michaelis-Menten 
equation.  





(Figure 3 figure supplement 1A) Steady-state kinetics of PPiase. Calculated kcat/KM is ~ 675,000M
-
1sec-1, which is about 1,000-fold faster than that of cGAS in the presence of saturating 564-bp 
dsDNA (~750 M-1sec-1). 
(Figure 3 figure supplement 1B) Steady-state NTase rates of dsDNA free cGAScat (estimated 






(Figure 3 figure supplement 2A) Table summarizing activation parameters. 
(Figure 3 figure supplement 2B) A plot of the half-maximal dsDNA concentrations (Kact) required 
to activate cGAS (i.e. apparent binding affinity) vs. dsDNA lengths. 
(Figure 3 figure supplement 2C) A plot of the maximal dsDNA induced NTase activity of cGAS 
(kmax) vs. dsDNA lengths. 
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The N-domain potentiates cGAS dimerization  
It was recently reported that the N-domain of cGAS (residues 1-156) plays an important role in 
vivo by providing an additional nonspecific dsDNA binding site (Tao et al. 2017; Wang, Ning, et 
al. 2017). Moreover, it was proposed that the N-domain reduces the requirement for long dsDNA, 
because it facilitates the activation of monomeric, mouse cGAS (Lee et al. 2017). To test whether 
our findings with cGAScat apply to the full-length enzyme, we generated recombinant cGASFL. 
The full-length protein eluted as two peaks in SEC (Figure 4A), exhibited monomer-dimer 
behavior by SAXS (Figure 4B, and Figure 4-figure supplements 1B-C), and was free from nucleic 
acid contamination (Figure 4-figure supplement 1A). Of note, it appeared that cGASFL has a higher 
dimerization propensity compared to cGAScat, as indicated by broader peak distribution at 15 µM 
(Figure 4A vs. Figure 1A). Supporting this notion, SAXS analyses also suggested that the 
dimerization constant of cGASFL is about 2-fold less than cGAScat (Figure 4-figure supplement 
1B-C; cGAScat is 48% dimeric at 15 µM; Figure 1C-D). To further test that the N-domain can 
dimerize, we generated recombinant N-domain (cGASN). cGASN migrated as a dimer by SEC, and 
had a SAXS-estimated molecular weight consistent with a dimer (Figure 4-figure supplement 2A-
C). Of note, in our solution equilibrium assay, cGASN bound dsDNA much more weakly than 
cGAScat, which is in contrast to the non-equilibrium mobility assay used by Tao et al. ((Tao et al. 
2017); Figure 4-figure supplement-2D-E; KD > 10 µM). These observations suggest a new role of 
N-domain in assisting the dimerization of cGAS. 
 
cGASFL still bound dsDNA in a length dependent manner (Figure 4-figure supplement 3A), and 
displayed dsDNA length-dependent changes in FRET (Figure 4C, Figure 4-figure supplement 3B). 
KFRETs for dsDNA > 72-bp were roughly equivalent to the lowest enzyme concentration practically 
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accessible in our assays (Figure 4C, Figure 4-figure supplement 3B), indicating that the full-length 
protein binds and dimerizes more readily on dsDNA. Substrates and their analogues also produced 
more robust changes in FRET signals for cGASFL compared to cGAScat (Figure 4D, Figure 4-figure 
supplements 3B-C), further corroborating that the full-length enzyme couples substrate binding to 
dimerization more efficiently due to its enhanced intrinsic dimerization activity. We also found 
that dsDNA length graded Kact and kmax of cGAS
FL, similar to cGAScat (Figure 4E, Figure 4-figure 
supplement 3D); KM and kcat for cGAS
FL were also graded according to dsDNA lengths (Figure 
4F, Figure 4-figure supplement 3E-F). Overall, our observations indicate that cGASFL and cGAScat 
operate within the same molecular framework, and reveal a new role for the N-domain in 





Figure 4. cGASFL operates within the same allosteric framework as cGAScat 
(A) SEC of cGASFL (Superdex 200 10/300). 
(B) Pair-wise distance distribution function  of cGASFL. 
(C) Changes in the ratio between the FRET donor emission (λmax: 578 nm) and the acceptor 
emission (λmax: 678 nm) of labeled cGAS
FL (20 nM each) at indicated dsDNA concentrations. 
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(D) Changes in the ratio between the FRET donor/acceptor emission ratio of labeled cGASFL (20 
nM each) at indicated NTP pair concentrations. 
(E) A plot of the dsDNA concentration-dependent NTase activity of cGASFL (25 nM) and 800 µM 
ATP/GTP with various duplex lengths. Lines are fits to a Hill form of the Michaelis-Menten 
equation.  
(F) Substrate dependence of the steady-state rate of NTase activity by cGASFL (125 nM) with 





(Figure 4 figure supplement 1A) Uv-vis spectra of cGASFL showing no significant nucleic acid 
contamination, and SDS-PAGE of cGAScat and cGASFL.  SDS-PAGE gel shows > 95% pure 
cGASFL and cGAScat.  
(Figure 4 figure supplement 1B) SAXS scattering profile of cGASFL. 





(Figure 4 figure supplement 2A) SEC of cGASN (Superdex 75 16/600). 
(Figure 4 figure supplement 2B) SAXS scattering profile of cGASN. 
(Figure 4 figure supplement 2C) Table summarizing SAXS analyses of cGASFL. 
(Figure 4 figure supplement 2D-E) Binding of cGASN to each FAM-labeled dsDNA (5 nM) was 





(Figure 4 figure supplement 3A) Competition binding assay using 72-bp FAM-dsDNA (5 nM) and 
cGASFL (50 nM) against various dsDNA lengths; the lines are fits to a competition binding 
equation: (1/(1+(dsDNAcompetitor)/IC50)
Hill constant ).  




(Figure 4 figure supplement 3C) Competition activity assay using 339-bp dsDNA (4 µg/ml) and 
cGAScat (50 nM) and 150 µM ATP/GTP against increasing concentrations of AMPcPP/GMPcPP; 
the lines are fits to a competition binding equation: (1/(1+(competitor)/IC50)
Hill constant. The Ki was 
calculated using the Cheng-Prusoff equation. 
(Figure 4 figure supplement 3D) Table summarizing activation parameters of cGASFL (25 nM, 800 
µM ATP/GTP). 
(Figure 4 figure supplement 3E) Steady-state NTase rates of dsDNA free cGASFL (estimated 
kcat/KM ≈ 400 M
-1 min-1) 
(Figure 4 figure supplement 3F) Table summarizing steady-state kinetic parameters of cGASFL 




Dimerization is required for dsDNA-mediated activation 
Although 24-bp dsDNA failed to induce dimerization (Figures 2C and 4C), it activated cGAS to a 
significant extent (Figures 3C and 4E). Monomeric cGAS can also bind dsDNA, but it is thought 
to be poorly activated (Andreeva et al. 2017; Li et al. 2013). Moreover, it was proposed that the 
N-domain enhances the dsDNA binding of monomeric cGAS (Tao et al. 2017), thereby activating 
the enzyme by lifting the dimerization requirement (Lee et al. 2017). Nonetheless, 24-bp dsDNA 
bound and activated both cGAScat and cGASFL only moderately (Figures 3C and 4E).  Thus, our 
data are most consistent with the allosteric model in which the presence of ATP/GTP increased 
the dimeric fraction, allowing the short dsDNA to activate cGAS to some extent (Figures 2A-B). 
To further test this idea, we characterized the activities of a cGAS mutant that binds dsDNA but 
fails to dimerize, K394E (Li et al. 2013; Zhang et al. 2014); Figure 5A. 
 
Both K394E-cGAScat and K394E-cGASFL behaved as single monomeric species in SEC (Figure 
5B and Figure 5-figure supplement 1A), consistent with previous reports (Li et al. 2013; Zhang et 
al. 2014). SAXS and AUC experiments corroborated that K394E-cGAScat is predominantly 
monomeric at all tested concentrations (Figure 5-figure supplements 1B-D). Compared to wild-
type, not only did K394E-cGAScat bind dsDNA more weakly, but also without length dependence 
(Figure 5-figure supplement 2A). The dsDNA length-dependence of K394E-cGASFL was also less 
pronounced compared to wild-type cGASFL (Figure 5-figure supplement 2B-C). We predict that 
the dsDNA length dependence of K394E-cGASFL likely arise from the dimerization of the N-
domain. Importantly, without dsDNA, K394E-cGAS showed similar activities as wild-type; 
however, dsDNA failed to stimulate the enzymatic activity of the mutants regardless of duplex 
length (Figures 5C-F). For instance, dsDNA marginally decreased the KM of K394E-cGAS, but 
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the kcat did not increase significantly (Figures 5D and 5F). Our results also support the idea that 
monomeric cGAS can bind substrate and is basally active, yet dimerization is necessary for 
dsDNA-induced and dsDNA length-dependent activation regardless of the intact N-domain. 
Furthermore, our observations support the idea that short dsDNA and substrates can synergistically 





Figure 5. Monomeric cGAS is basally active, but cannot be further activated by dsDNA 
(A) Crystal structure of dimeric cGAScat. The loop important for dimerization is colored in 
magenta and Lys394 is shown in stick representation (PDB ID: 4lez). 
(B) SEC (Superdex 200 10/300) of K394E-cGASFL. WT-cGASFL is shown for reference (blue). 
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(C) A plot of the dsDNA-concentration dependent NTase activity of K394E-hcGAScat (1 µM) and 
1 mM ATP/GTP with different duplex lengths. 
(D) Substrate dependence of the steady-state rate of NTase activity by K394E-hcGAScat (1 µM) in 
the absence or presence of each dsDNA (6X Kact).  Lines are fits to a Hill form of Michaelis-
Menten equation.  
(E) A plot of the dsDNA-concentration dependent NTase activity of K394E-cGASFL (125 nM) 
and 1 mM ATP/GTP with different duplex lengths. 
(F) Substrate dependence of the steady-state rate of NTase activity by K394E-cGASFL (125 nM) 







(Figure 5 figure supplement 1A) SEC of K394E-cGAScat (Superdex75 16/600). 
(Figure 5 figure supplement 1B) SAXS scattering profile of K394E-cGAScat. 
(Figure 5 figure supplement 1C) Pair-wise distance distribution function calculated from Figure 5 
figure supplement 1B. 






(Figure 5 figure supplement 2A) Binding of K394E-cGAScat to each FAM-labeled dsDNA (5 nM) 
was determined by FA. The lines are fits to a standard binding isotherm. 
(Figure 5 figure supplement 2B) Binding of K394E-cGASFL to each FAM-labeled dsDNA (5 nM) 
was determined by fluorescence anisotropy (FA). The lines are fits to a standard binding isotherm. 
(Figure 5 figure supplement 2C) Binding of cGASFL to each FAM-labeled dsDNA (5 nM) was 
determined by fluorescence anisotropy (FA). The lines are fits to a standard binding isotherm.  
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cGAS dimers arrange randomly on dsDNA 
cGAS dimers are thought to form a ladder-like array along the length of dsDNA to maximize the 
stability of its signaling complex (Andreeva et al. 2017). Given that both cGAS monomers and 
dimers bind dsDNA (Andreeva et al. 2017; Li et al. 2013), our results are better explained by a 
simpler mechanism in which dsDNA length regulates the fraction of cGAS dimers without 
requiring an ordered structure beyond the dimeric unit (Figures 2A-B). To further test this idea, 
we imaged cGAScat and cGASFL with dsDNA using nsEM (Figure 6; see also Figure 6- figure 
supplement 1 for zoom-in images, and additional images in figure 6- figure supplement 2). When 
proteins were in excess over dsDNA, we observed large clusters likely reflecting multiple cGAS 
dimers binding to several different dsDNA strands (Figure 6A and 6E). It is possible that these 
clusters reflect the recently observed phase-shifting condensates of cGAS•dsDNA (Du and Chen 
2018a). With excess dsDNA over protein, which more likely resembles in vivo events when 
dsDNA breaches the cytoplasm, it appeared that cGAS dimers randomly decorated dsDNA 
(Figures 6B and 6F), with the particle sizes corresponding to the dimeric species of cGAScat and 
cGASFL, respectively (i.e. the Dmax for these constructs are ~10 and 18 nm, respectively; Figure 
1). Importantly, the ladder-like arrangement of cGAS particles was rare for both cGAScat and 
cGASFL (Figure 6B and F, Figure 6-figure supplement 2D-E), suggesting that cGAS•dsDNA does 
not form an ordered supra-structure.  
 
 On the other hand, the size of particles resulting from excess K394E-cGAScat with dsDNA 
appeared smaller and corresponded to the Dmax of cGAS monomers (Figure 6C; see also Figure 5-
figure supplement 1), likely reflecting monomeric cGAS randomly bound on dsDNA. For K394E-
cGASFL, we observed dsDNA-bound clusters somewhat similar to wild-type (these clusters are 
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likely mediated by the intact N-domain that promotes dimerization). However, the clusters were 
not as expansive as those formed by wild-type (Figure 6E vs. G). Moreover, we did not observe 
any significant decoration of dsDNA when the K394E mutants were present in sub-stoichiometric 
amounts (Figures 6D and 6H; the particle size observed in Figure 6H also corresponds to the 
monomeric full-length cGAS). Overall our nsEM experiments support the allosteric framework of 
cGAS (Figure 2A-B) in which the role of dsDNA length is to simply bias the fraction of active 
dimers without necessitating supramolecular assemblies. Nevertheless, given the intrinsic, low-
resolution imaging of nsEM, future structural studies are warranted to more fully understand the 





Figure 6. cGAS dimers assume various configurations on dsDNA 
Negative-stain electron micrographs of  cGAS•dsDNA complexes. (A, E) 3-fold excess cGAS 
over dsDNA, (B, F) 3-fold excess dsDNA over cGAS, (C, G) 3-fold excess K349E-cGAS over 
dsDNA, (D, H) 3-fold excess dsDNA over K394E-cGAS. Ratios of protein to dsDNA or dsDNA 
to protein are binding site normalized; 18 bp per binding site. The particle sizes in B and F are 
consistent with the Dmax of cGAS
cat and cGASFL, respectively (Figures 1 and 4). Particle sizes in 





(Figure 6 figure supplement 1A-E) Zoomed-in images from Figures 6B, C, F, and H showing the 










The context-dependent, allosteric activation of cGAS 
It was initially proposed that dsDNA length does not play a significant role in regulating the 
activation of cGAS (Gao, Ascano, et al. 2013; Kranzusch et al. 2013; Li et al. 2013); however, two 
recent studies have contested this model (Andreeva et al. 2017; Luecke et al. 2017b). The reason 
for this discrepancy is still unclear. Our results suggest that raising enzyme and substrate 
concentrations will increase the dimeric fraction of cGAS, while binding of short dsDNA will not 
(e.g. 24-bp). Given the vastly different cGAS and substrate concentrations used in previous studies 
(Gao, Ascano, et al. 2013; Kranzusch et al. 2013; Li et al. 2013; Andreeva et al. 2017; Luecke et 
al. 2017b), we speculated that the apparent or lack of dsDNA length-dependence is caused by the 
fraction of cGAS dimers formed without dsDNA (Figure 2A). To test this idea, we monitored the 
steady-state NTase activity of cGAScat and cGASFL with saturating amounts of various dsDNA 
lengths and a permutation of high and low concentrations of enzyme and ATP/GTP (Figure 7A-
D). Increasing substrate and enzyme concentrations did not eliminate the need for dsDNA. 
However, the dependence on dsDNA length progressively decreased with increasing protein and 
substrate concentrations. For instance, with low cGAScat and sub-KM ATP/GTP concentrations 
(cGAS is predominantly monomeric), we observed strong dsDNA length-dependent activities, 
with a difference of 8-fold between 24-bp and 564-bp dsDNA (Figure 7A). With low cGAS and 
high ATP/GTP, the difference between short and long dsDNA was 4-fold (Figure 7B). With high 
cGAS and low ATP/GTP, the difference was again reduced to 2.5-fold (Figure 7C). Finally, with 
high cGAScat and high ATP/GTP (the dimer population is significant), the differential activity 
caused by various dsDNA lengths was merely 1.5-fold, with short dsDNA molecules robustly 
activating cGAScat (Figure 7D). Furthermore, we observed the same trend from cGASFL except the 
effect of raising substrate and enzyme concentrations was more pronounced than cGAScat (Figure 
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7-figure supplement 1). These observations uncover the reason for conflicting observations 
regarding dsDNA length-dependence (Andreeva et al. 2017; Li et al. 2013; Kranzusch et al. 2013; 
Luecke et al. 2017b). That is, the dependence on dsDNA length can either manifest or diminish by 
different reaction contexts that dictate the fraction of dsDNA-free cGAS dimers. Our results in 
turn indicate that cGAS is primed to generate a graded signaling output depending on the overall 
reaction condition (e.g. the length of cytoplasmic dsDNA, cGAS expression level, and available 
ATP/GTP), providing a molecular framework for its context-dependent and diverse stress 






Figure 7. Context-dependent activation of cGAS  
(A-D) Plots of the NTase activity of cGAScat vs. dsDNA length (6X-Kact) at various enzyme and 
substrate concentrations (low cGAS: 50 nM, High cGAS: 1 µM; low ATP/GTP: 250 µM, high 
ATP/GTP: 6X-KM for each dsDNA). The NTase activity of cGAS
cat induced by 564-bp dsDNA 
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was normalized by enzyme and substrate concentrations, and used as the reference to calculate the 
fraction activity for each dsDNA length (n = 3; ± SD). 
(E) The equilibrium-based activation model of cGAS. Diamonds represent basally active cGAS 
and circles indicate active cGAS. Filled shapes and thicker lines indicate dsDNA binding and 
substrate binding, respectively. Thicker lines and darker shades indicate stronger interactions.  
 
 
(Figure 7 figure supplement 1A-D) Plots of the NTase activity of cGASFL vs. dsDNA length (6X-
Kact) at various enzyme and substrate concentrations (low cGAS: 25 nM, High cGAS: 1 µM; low 
ATP/GTP: 150 µM, high ATP/GTP: 6X-KM for each dsDNA). The NTase activity of cGAS
FL 
induced by 564-bp dsDNA was normalized by enzyme and substrate concentrations, and used as 




The activation of IFN-1 leads to diverse stress responses (antiviral gene expression, cellular 
senescence, autophagy, or apoptosis; (Gulen et al. 2017; Larkin et al. 2017; Li and Chen 2018; Li 
et al. 2016; Tang et al. 2016; Liang et al. 2014; Yang et al. 2017)). cGAS contributes significantly 
to this complex signaling landscape by generating variable amounts of cGAMP (Li and Chen 
2018). Here, building upon the framework shown in Figure 2A, we set forth a unifying allosteric 
activation mechanism of cGAS, which explains how this cytoplasmic dsDNA sensor could 
dynamically tune its signaling activity in a switch-like fashion according to reaction (cellular) 
contexts (Figure 7E). In this model, cGAS is subject to an intrinsic, monomer-dimer equilibrium, 
with its N-domain potentiating the dimerization propensity. dsDNA can drive the monomer-dimer 
equilibrium toward the dimeric state, with duplex length determining the fraction of active dimers 
(Figure 7E upper right-hand path). Importantly, given the active unit of cGAS is a dimer, we 
propose that longer dsDNA simply increases the probability of forming dimers without invoking 
an ordered configuration. We also find here that cGAS allosterically couples its dimeric population 
to factors other than dsDNA, such as cGAS expression level and ATP/GTP availability (Figure 
7E, left path). We propose that this coupling mechanism would allow the dimer population to be 
in constant flux, providing a molecular framework for its dynamic signaling activity. Indeed, 
cGAS is subject to overexpression by multiple factors including its downstream product IFN-1 
(Ma et al. 2015). Intracellular ATP/GTP concentrations also vary depending on cell age, cell-cycle 
progression, and stress conditions (Traut 1994; Huang, Zhang, and Chen 2003; Corton, Gillespie, 
and Hardie 1994; Wang et al. 2003; Marcussen and Larsen 1996). Moreover, post-translational 
modification (e.g. mono-ubiquitination) promotes dimerization of cGAS (Seo et al. 2018). Of note, 
given that pathogen infection increases host NTP levels (Ogawa et al. 2015; Chang et al. 2009), it 
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is tempting to speculate that cGAS takes advantage of the higher intracellular NTP levels to 
increase its dimer population, potentiating its activation. Importantly, increasing the dimeric 
fraction in the absence of dsDNA would not elicit significant spurious activity, but would instead 
prime the enzyme for facile activation by reducing the dependence on dsDNA length (Figure 7E 
lower left-hand corner). Another key feature of our equilibrium-based allosteric model is that 
dsDNA length-dependence is conditional, reconciling conflicting claims regarding the dependence 
on dsDNA length in activating cGAS (Andreeva et al. 2017; Gao, Ascano, et al. 2013; Kranzusch 
et al. 2013; Li et al. 2013; Luecke et al. 2017b; Zhang et al. 2014).  
 
Molecular framework for the dsDNA length-dependent response of cGAS 
As the initial receptor in a major inflammatory signaling pathway (Chen, Sun, and Chen 2016), it 
is critical for cGAS to possess a very stringent noise filtering mechanism. Although cGAS binds 
dsDNA in a sequence-independent manner (Gao, Ascano, et al. 2013; Li et al. 2013; Zhang et al. 
2014), it uses dsDNA length to distinguish signal from noise (Andreeva et al. 2017; Luecke et al. 
2017b). After all, dsDNAs arising from catastrophic conditions are significantly longer than 300 
bps (e.g. mitochondrial, chromosomal, and viral dsDNA), while short dsDNAs likely indicate 
minor genome repair and/or resolution of infection (i.e. the viral genome has been degraded). Here, 
we find that the allosteric coupling mechanism allows cGAS to generate a two-stage noise filter 
against short dsDNA. For instance, as others have reported (Andreeva et al., 2017), we recapitulate 
here that cGAS binds and dimerizes on dsDNA in a length-dependent manner. We also found that 
dsDNA length-dependent dimerization and binding in vitro only gradually changes (Figures 2-4; 
(Andreeva et al., 2017)). However, dsDNA length also grades the enzymatic activity of cGAS 
(Figures 3-4). Thus, combined with the length-dependent complex formation of cGAS dimers 
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(signal recognition), the length-dependent enzymatic activity (signal transduction) would allow 
cGAS to further differentiate correct pathogenic dsDNA from noise (short dsDNA). Of note, given 
that dsDNA length-dependence subsides with high concentrations of cGAS, our new model also 
provides an avenue for how improper clearance of pathogenic or self-dsDNA can induce spurious 
activity of cGAS leading to auto-inflammatory conditions (Gao et al. 2015; Li and Chen 2018). 
 
The role of cooperativity in initiating and terminating the cGAS pathway 
The interactions between cGAS and its ligands (dsDNA and ATP/GTP) display positive 
cooperativity, a hallmark of allosteric enzymes (Figures 2-4). One key feature of a cooperative 
system is its capacity to amplify and attenuate the output in a switch-like manner (Sohn and Sauer 
2009; Monod, Wyman, and Changeux 1965). For instance, when the concentrations of cGAS, 
dsDNA, and ATP/GTP change by a factor of two, a non-cooperative system would yield a total 8-
fold increase in output (2x2x2 = 8). However, because cGAS requires dimerization for activity 
and displays a Hill constant near two in its interaction with both dsDNA and ATP/GTP, the same 
two-fold change would be further amplified by the exponent of two, leading to a 64-fold 
amplification in output (22x22x22 = 64). Conversely, the same cooperative mechanism would allow 
cGAS to attenuate its signaling output by the same magnitude with decreasing enzyme and ligand 
concentrations. Together with the dsDNA-length dependent activity, the cooperativity would 
enable cGAS to dramatically alter its output according to the changes in input parameters, allowing 
the initial receptor to dynamically regulate its signaling pathway in a switch-like manner.  
 
The role of N-domain and human vs. mouse cGAS 
78 
 
Although cGAScat is sufficient to bind dsDNA and generate cGAMP in vitro, the intact N-domain 
is crucial for augmenting its function in cells (Tao et al. 2017; Wang, Ning, et al. 2017). It has 
been presumed that the major role of the N-domain is to enhance dsDNA binding (Lee et al. 2017; 
Tao et al. 2017). Furthermore, it was proposed that the N-domain promotes the activation of 
monomeric mouse cGAS by dsDNA (Lee et al. 2017). Here, we found that N-domain potentiates 
the dimerization of cGAS. Our results also indicate that dimerization is necessary for dsDNA-
mediated activation by both cGAScat and cGASFL (Figure 5). It is possible that mouse cGAS 
operates in a different mechanism than human cGAS. Indeed, it was recently proposed that mouse-
cGAS would not depend on dsDNA length as much as human-cGAS for activation, as the former 
binds short dsDNA more tightly (Zhou et al. 2018). However, it was previously shown that both 
human and mouse-cGAS exhibit similar dsDNA length dependent activation (Andreeva et al. 
2017). Considering that dsDNA-mediated dimerization is critical for both human and mouse cGAS 
variants for activation (Andreeva et al. 2017; Li et al. 2013; Zhang et al. 2014; Zhou et al. 2018), 
we propose that our findings are likely general phenomena across different species, and different 
intrinsic affinity constants caused by diverse primary sequences (Zhou et al. 2018) would dictate 
species-specific experimental observations. 
 
Comparison with other nucleic acid sensors 
Absent-in-melanoma-2 (AIM2) is another major cytoplasmic dsDNA sensor in mammals 
(Fernandes-Alnemri et al. 2009; Hornung et al. 2009; Roberts et al. 2009). The single most 
important goal of the AIM2-mediated dsDNA sensing pathway is to induce cell-death, a digital 
(not tunable) process that does not require a new equilibrium (Liu et al. 2014; Roberts et al. 2009). 
Indeed, once assembled on dsDNA, the AIM2 inflammasome does not disassemble and multiple 
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positive feedback loops reinforce the assembly, consequently generating a binary signaling 
response (Matyszewski, Morrone, and Sohn 2018). By contrast, the cGAS signaling pathway 
elicits various stress-responses ranging from viral replication restriction to apoptosis, with the 
signal strength and cellular contexts determining the type of outcome (Gulen et al. 2017; Larkin et 
al. 2017; Li and Chen 2018; Li et al. 2016; Tang et al. 2016; Liang et al. 2014; Yang et al. 2017). 
Unlike AIM2, we find here that cGAS can dial its own activity (tunable), providing a molecular 
framework for eliciting various cGAMP-dependent outcomes. Furthermore, although both AIM2 
and cGAS are activated in a dsDNA length-dependent manner, the former assembles into filaments 
(Matyszewski, Morrone, and Sohn 2018; Morrone et al. 2015), while the latter only requires 
dimerization. Likewise, although cytoplasmic dsRNA sensors preferentially target long duplexes 
(> 500 bps), MDA5 assembles into filaments while RIG-I does not require polymerization for 
activation (Sohn and Hur 2016; Linehan et al. 2018; Peisley et al. 2011; Ramanathan et al. 2016; 
Peisley et al. 2013). Thus, we propose that the assembly of supra-structures is not universal to host 
nucleic acid sensors. Rather, it appears that each sensor has evolved unique mechanisms to utilize 
the length of nucleic acids as a molecular ruler to distinguish self (noise) from nonself (signal).  
 
Extended discussion 
Not surprisingly, human and mouse cGAS share many structural and functional properties. Based 
on sequence alone, the catalytic domain is >65% identical, while the N-terminal extension is less 
conserved (<25%). Both proteins share a nucleotidyl transferase fold and a flexible N-terminal 
extension. From a functional perspective, human and mouse cGAS are the primary drivers of 
interferon signaling in cells when challenged by microbes, viruses or dsDNA. Both require dsDNA 
for activation, and, when activated, they perform two, sequential nucleotidyl transfer reactions to 
80 
 
create cGAMP from ATP and GTP. Lastly, both homologs inherently discriminate against 
stimulatory dsDNAs based on length, albeit to different extents, at least in vitro. No direct 
comparison has/can be made in cells.  
Despite their similarities, human and mouse cGAS appear to achieve the same end goal through 
slightly different means. Human cGAS can dimerize in the absence of dsDNA, while mouse cGAS 
appears to do so only in the crystalline state. Mouse cGAS binds more tightly to short dsDNA and 
is more active when bound to short dsDNA. Lastly, mouse cGAS is significantly more efficient 
with respect to NTase activity relative to human cGAS. This phenomenon is primarily manifested 
by relatively tighter functional binding of substrates and an elevated kcat (Zhou et al. 2018).  
Crystal structures of human* and mouse cGAS in the presence and absence of dsDNA have been 
solved. All crystallographic forms of cGAS are dimeric, enabling an accurate molecular 
comparison of the two homologs. Close inspection of the dimerization interface reveals a potential 
clue as to why human cGAS dimerizes more efficiently than mouse cGAS. The loop sandwiched 
between the dimeric interface and Zn-binding motif, residues N399-E402 (human), referred to as 
the bridging loop hereafter, is noticeably dissimilar between human and mouse cGAS (Figure). 
Notably, the human loop orients the acidic side chain of E402 to point towards K392. This 
electrostatic interaction is not capable of forming in the mouse dimer due to the different loop 
conformer preference and residue substitutions at both E402 and K392 (A390 and I380 in mouse, 
respectively). Moreover, symmetry at the dimerization interface implies that the additional 
electrostatic interaction occurs twice, thereby doubling the energy contribution towards 
dimerization.  
Multiple studies have shown that mcGAS turns over significantly faster than hcGAS (20 min-1 vs 
2 min-1). The molecular mechanism for this remains uncertain, but the determinants for this effect 
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appear to hinge, at least, on two key residues, K187 and L195 (human). Curiously, the residues 
are within the primary dsDNA binding site on the spine helix. Authors of the study claim that the 
mouse residues, N for K187 and R for L195, enhance DNA binding affinity for short dsDNA while 
negligibly affecting the binding affinity for long dsDNA. This implies then that the human residues 
polarize the hcGAS response to favor activation by long dsDNA. However, this model seemingly 
contradicts published data showing that both mcGAS and hcGAS respond in a dsDNA-length 
dependent manner in cells. Moreover, the authors did not explain how an increase in dsDNA 
binding affinity could result in dramatically faster catalytic rates. One possibility is that the 
residues within the spine helix dictate how the grooves of dsDNA orient within the dsDNA binding 
site. Shifting the register of the DNA, i.e. location of the major and minor groove, may influence 
how dsDNA effectively promotes the necessary conformational change at the active site, e.g. 
ordering the activation loop. It is worth noting that the adjacent dsDNA binding site on the second 
protomer, site B, may also influence the dsDNA binding register, and that mcGAS and hcGAS 
also differ in primary sequence at this location. Additional experimentation, perhaps through 
mutagenesis, is necessary to test these hypotheses.  
All structures have captured cGAS in the dimeric state. Thus, it remains unclear if the crystalline 
form of cGAS biases the conformation of key structural features, such as the bridging loop. If the 
bridging loop of apo, monomeric cGAS can adopt alternative conformations, this would indicate 
that dsDNA binding and dimerization are also linked by the bridging loop. Evidence for this is 
seen from a mutant that disrupts the adjacent Zn-binding motif. The mutant phenocopies the 
dimerization-null mutant K394E, suggesting that, in addition to disrupting dsDNA contacts, the 
Zn-binding mutant lacks the structural integrity to dimerize; the Zn-binding motif constrains the 





In closing, our study reconciles the conflicting views on the roles of dsDNA length and the N-
domain in activating cGAS. We also provide a mechanistic framework for understanding how 
cGAS can shape a complex signaling landscape depending on cellular reaction contexts. Future 
studies will be directed in understanding how this dynamic enzyme operates in conjunction with 
its downstream and regulatory components to regulate host innate immune responses against 
cytoplasmic dsDNA.  
 
Materials and Methods 
Reagents 
dsDNA substrates and oligonucleotides shorter than 100 bps were purchased from Integrated DNA 
Technologies (IDT). Longer dsDNAs (≥ 150 bps) were generated by PCR. The human cGAS 
cDNA was kindly provided by Dr. Dinshaw Patel. E. coli pyrophosphatase was a gift from Dr. 
James Stivers. The SortaseA (SortA) enzyme was a gift from Dr. Hidde Ploegh. Purity and length 
of each dsDNA was confirmed by agarose gel electrophoresis. TAMRA- and Cy5-labeled peptides 
were purchased from Lifetein. ATP and GTP were purchased from Sigma. GMPcPP and AMPcPP 
were purchased from Jena Biosciences 
 
Recombinant cGAS purification 
Protein preparation. Recombinant cGAS constructs were cloned into the pET28b vector 
(Novagen) with an N-terminal 6xHis-MBP-tag and a TEV protease cleavage site. Proteins were 
expressed using 200 µM IPTG at 16°C for overnight in E. coli BL21 Rosetta 2. Cells were lysed 
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in Buffer A by sonication (Buffer A: 25mM Tris HCl pH 7.5, 1mM DTT, 5% glycerol, 500mM 
NaCl, PMSF, lysozyme, benzamidine, DNaseI). Clarified lysate was applied to amylose resin, and 
then washed with 4CV of Buffer B before eluting with Buffer B supplemented with maltose 
(Buffer B: 25mM Tris HCl pH 7.5, 1mM DTT, 5% glycerol, 500mM NaCl). The eluted fraction 
was dialyzed with TEV protease overnight at 4°C in buffer containing 25mM Tris HCl pH 7.5, 
125mM NaCl, 10mM -ME. After dialysis, the dialysate was adjusted to include 5% glycerol and 
supplemented to 300mM NaCl (Buffer C).  Recombinant cGAS constructs were then bound to 
heparin resin (GE Healthcare), washed extensively and flash eluted with Buffer C supplemented 
to 800mM NaCl. The eluted fractions were applied to a Superdex 75 16/60 (cGAScat and cGASNT) 
or Superdex 200 16/60 (cGASFL) in buffer containing 25mM Tris HCl, 300mM NaCl, 1mM DTT 
and 2% glycerol (Buffer D). Monomer and dimer peaks were combined and applied to amylose 
resin to remove residual, uncleaved protein. The flow through was concentrated then frozen and 
stored at -80°C in buffer containing 20 mM Tris HCl at pH 7.5, 300 mM NaCl, 10% glycerol, 5 
mM DTT. The preparation of cGAS for sortase A labeling was performed as above, with the 
following exceptions: clarified lysate was applied to amylose, washed, and eluted then applied to 
Ni-NTA, then washed and eluted. The elutions were applied to a Superdex 200 16/60, and the 
recombinant cGAS fractions were concentrated, frozen and stored in at -80°C. Mutagenesis was 
confirmed by sequencing.  
 
Fluorophore labeling. The labeling procedure was adapted from (Guimaraes et al. 2013). 20 µM 
MBP-TEV-cGAS-LPETGG-6xHis was incubated with 30 µM SortA, 250 µM fluorophore-
peptide in Sortase reaction buffer (50mM Tris HCl pH 7.5, 150 mM NaCl, 10 mM CaCl2, 5% 
glycerol, 2 mM DTT) at 25 ± 2 °C for 3 hrs on a rotator. Reactions were directly applied to 
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Superdex 200 10/300 GL (20 mM Tris HCl pH 8.0, 300 mM NaCl, 2% glycerol, 10 mM BME). 
Fractions containing cGAS were applied to Ni-NTA. Flow-through was applied to heparin resin 
and washed with Sizing Buffer (Buffer D). Protein was eluted with Sizing buffer supplemented 
with 600 mM NaCl. Eluted fractions were adjusted to 20 mM Tris HCl pH 7.5, 300 mM NaCl, 10 
% glycerol, 5 mM DTT and concentrated.  
 
Biochemical Assays 
All experiments were performed at least three times. The fits to data were generated using 
Kaleidagraph (synergy). Reported values are averages of at least three independent experiments 
and reported errors are standard deviations. All reactions were performed under 25 mM Tris 
acetate pH 7.4, 125 mM potassium acetate pH 7.4, 2 mM DTT, 5 mM Mg(acetate)2 pH 7.4, and 
5% glycerol at 25 ± 2 °C. 
 
dsDNA binding assays. Increasing concentrations of cGAS were added to a fixed concentration of 
fluorescein-amidite-labeled (FAM) dsDNA (5-10 nM final). Changes in fluorescence anisotropy 
were plotted as a function of cGAS concentration and fit to the Hill equation. For competition-
based experiments, unlabeled dsDNA was titrated against a fixed population of FAM-dsDNA72 
and cGAS ([protein] = KD,dsDNA72). Changes in fluorescence anisotropy (FA) was plotted against 
competitor dsDNA concentration and fit to yield IC50s.  
 
FRET-based oligomerization assays. 60 nM Cy5- and TAMRA-labeled MBP-TEV-cGAS-LPET-
GGGQC/K-fluorophore were incubated with TEV protease in cGAS reaction buffer at 25 ± 2 °C 
for 2 hrs. Increasing amounts of dsDNAs of different lengths or equimolar concentrations of 
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nucleotides were added to 20 nM cleaved FRET pair, and FRET efficiency was recorded until 
equilibrium was reached.  
 
Pyrophosphatase-coupled cGAS activity assay. cGAS activity was assayed using the 
pyrophosphatase-coupled assay developed by Stivers and colleagues (Seamon and Stivers 2015) 
with modifications. Briefly, cGAS was incubated with 50 nM E. coli pyrophosphatase, equimolar 
concentrations of ATP and GTP plus dsDNAs (where indicated) in the reaction buffer. At indicated 
time points, an aliquot was taken and mixed with an equal volume of quench solution (Reaction 
buffer minus Mg++ plus 25 mM EDTA). Quenched solutions were then mixed with 10 µl malachite 
green solution and incubated for 45 min at RT. Absorbance at ~620 nm was compared to an 
internal standard curve of inorganic phosphate to determine the concentration of phosphate in each 
well. Phosphate concentrations of control reactions devoid of recombinant cGAS were subtracted 
from reactions containing recombinant cGAS. Apparent catalytic rates were calculated from the 
slopes of control-subtracted phosphate concentrations over time. Reported rates were halved to 
reflect pyrophosphate production. Average values are listed in Tables.  
 
nsEM. Experiments were conducted using a Philips BioTwin CM120 (FEI) as described previously 
(Morrone et al. 2015).  
 
SAXS data collection and analysis 
SAXS data was collected on the BIOSAXS 2000 (Rigaku) at the X-ray facility of the Department 
of Biophysics and Biophysical Chemistry at Johns Hopkins School of Medicine. Data was 
collected on at least three different concentrations for each sample. Samples with scatter showing 
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significant inter-particle effects were omitted from data analysis. Buffer-subtracted scatter was 
processed in Scatter (Petoukhov and Svergun 2013; Petoukhov et al. 2012; Mylonas and Svergun 
2007) and with the ATSAS package (Petoukhov and Svergun 2013; Petoukhov et al. 2012; 
Mylonas and Svergun 2007). Particle dimensions were compared between guinier analysis and 
real-space fitting of the scatter to ensure internal consistency of the data and fits. Estimates of 
average and relative molecular weights of each sample were estimated using porod volumes 
(Petoukhov and Svergun 2013; Petoukhov et al. 2012; Mylonas and Svergun 2007) and mass-
normalized I0 values. The distribution of monomeric and dimeric species was calculated using 
SAXS-estimated molecular weights and OLIGOMER. IN OLIGOMER, crystal structures of 
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Cytosolic double-stranded (ds)DNA is a hallmark of cellular stress. For instance, genomic 
instability, microbial infection and organelle failure can all result in release of dsDNA into the 
cytoplasm (Mackenzie et al. 2017; Harding et al. 2017; White et al. 2014; West et al. 2015; Riley 
et al. 2018; Ishikawa, Ma, and Barber 2009). Cyclic GMP-AMP synthase (cGAS), a pattern 
recognition receptor of the innate immune system, is the primary initiator of the cellular stress 
response to cytosolic dsDNA, and triggers induction of type-I interferons (IFN-I) upon dsDNA 
detection (Sun et al. 2013). Binding of dsDNA enables cGAS to cyclize ATP and GTP into the 
unique second messenger, cyclic GMP-AMP (cGAMP), bearing mixed-linkage phosphodiester 
bonds (Ablasser et al. 2013; Diner et al. 2013; Gao, Ascano, et al. 2013). cGAMP binds and 
activates STING, which facilitates TBK1 recruitment and activation of transcription factors, IRF3 
and NF- B. The strength of cGAS signaling varies with stimulus which results in diverse cellular 
outcomes highlighting a need to understand how cGAS activity is regulated (Gluck et al. 2017; 
Gulen et al. 2017; Andreeva et al. 2017)  
 
The mechanistic link between dsDNA binding and cGAS activity is well established. Structural 
studies of cGAS in the presence and absence of dsDNA illustrate how dsDNA binding orients the 
active site for catalysis (Civril et al. 2013; Li et al. 2013; Shu, Li, and Li 2014; Zhang et al. 2014). 
dsDNA is also crucial for promoting cGAS dimerization, a requisite for cGAS activity (Li et al. 
2013; Zhang et al. 2014). Importantly, the ease of cGAS dimerization is directly linked to dsDNA 
length, which manifests in graded cGAS activity both in cells and in vitro (Andreeva et al. 2017; 
Luecke et al. 2017a; Hooy and Sohn 2018). Although some evidence suggests that the dsDNA 
length-dependence spawns from formation of higher-order structural arrangements (Andreeva et 
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al. 2017), it remains controversial whether ordered structures beyond the dimeric unit are needed 
to achieve dsDNA length-dependent activity (Hooy and Sohn 2018).  
 
Additional studies have recently revealed that the degree of dsDNA length-dependent activity is 
tunable depending on reaction context. Substrate and cGAS concentrations toggle the sensitivity 
of cGAS to dsDNA length (Hooy and Sohn, 2018). It is also known that post-translational 
modifications can render resident cGAS populations to be less, or more active depending on the 
modification (Chen, Meng, et al. 2016; Hu et al. 2016; Wang, Huang, et al. 2017; Liu et al. 2018; 
Seo et al. 2018; Xia et al. 2016; Seo et al. 2015; Wang, Ning, et al. 2017). Extrinsic factors, such 
as protein co-sensors, can also aid or repress dsDNA sensing by cGAS (Almine et al. 2017; Biolatti 
et al. 2018; Shannon et al. 2018; Lian et al. 2018). More recently, zinc and manganese, divalent 
cations found ubiquitously in nature, were proposed to enhance cGAS activity. Zinc is thought to 
promote inter-strand crosslinking of cGAS-dsDNA complexes, which facilitates phase-separation 
and condensate formation, but in a dsDNA length-dependent manner (Du and Chen 2018b). 
Manganese was also shown to improve the cGAS-mediated response to viral challenge and dsDNA 
stimulation, but whether the manganese effect was dependent on dsDNA length was unclear 
(Wang, Guan, et al. 2018).    
 
Manganese, like magnesium, is a cofactor for various enzymes, including nucleotidyl transferases 
(NTases), and, in the +2 oxidation state, typically serves as a general Lewis acid to polarize 
phosphoryl groups and/or activate nucleophiles. Enzymes that use magnesium for catalysis 
oftentimes retain function when manganese is substituted as the cofactor (Vashishtha, Wang, and 
Konigsberg 2016). Although cGAS was shown to be more sensitive to dsDNA in the presence of 
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manganese (Wang, Guan, et al. 2018), it remained unclear whether the effect was due to changes 
in catalytic activity, or due to changes in the way cGAS interacted with dsDNA. Here we sought 
to determine the mechanism by which manganese contributes to the allosteric regulation of cGAS 
signaling in response to dsDNA.  
 
We find that manganese reduces the dsDNA length-dependent response of cGAS in cells and in 
vitro. This phenomenon is not due to a direct effect of manganese on dimerization or dsDNA-
induced dimerization, rather manganese increased the catalytic capacity of dsDNA-bound, 
monomeric and dimeric cGAS. Manganese can substitute for magnesium as the cofactor for 
catalysis, and in general, Mn2+ supports catalysis more efficiently than magnesium. Surprisingly, 
manganese alone is capable of activating monomeric cGAS, even in the absence of dsDNA, 
although relatively high concentrations of Mn2+ are required to achieve this auto-activation. 
Importantly, the functional binding affinity of Mn2+ is directly coupled to dsDNA binding, and 
vice versa, and this ultimately reduces the functional binding constant of Mn2+ to levels within the 
physiological range (Bowman and Aschner 2014). Lastly, low levels of manganese are sufficient 
to specifically accelerate cGAMP production, whereas elevated concentrations of manganese 
promote significant off-product catalysis. Moreover, we provide evidence that dsDNA binding 
contributes to the high fidelity coupling of ATP/GTP over other dinucleotide products. Together 
these data define the mechanistic role of Mn2+ in cGAS stress sensing, and bolster the validity of 





Manganese reduces the dsDNA length-dependent activity of cGAS 
It was recently demonstrated that lower concentrations of dsDNA were sufficient to stimulate 
cGAS when manganese was present, yet it remained unclear if the apparent increase in 
“sensitivity” to dsDNA applied to all lengths of dsDNA (Wang, Guan, et al. 2018). This is 
important given that cGAS activity in cells is dsDNA-length dependent. To test if dsDNA length-
dependence changes with Mn2+, cGAS activity was assayed in vitro using recombinant, full-length, 
human protein, cGASFL (Figure 1A). Under saturating levels of dsDNA, cGASFL displayed 
increased activity as a function of dsDNA length, consistent with previous findings.  In the 
presence of 50uM Mn2+, the difference in rates between short and long dsDNA reduced 
dramatically. Thus, the reduced difference in dsDNA length-dependent activity in cells is due to a 
direct effect of Mn2+ on cGAS.  
 
cGAS activity that is less dependent on dsDNA length could be explained in two ways (Figure 
1B). First, Mn2+ could directly influence the ability of cGAS to dimerize. Dimerization is thought 
to be essential for cGAS to be active (Li et al. 2013; Zhang et al. 2014). Moreover, enhanced 
dimerization would effectively increase the binding affinity for dsDNA, especially short dsDNA, 
similar to the effect achieved by the N-terminal extension (Hooy and Sohn 2018; Tao et al. 2017) 
or post-translational modifications (Seo et al. 2018).  Alternatively, Mn2+ could serve as a cofactor 
for catalysis and promote faster turnover of substrate. Mn2+ is known to substitute for Mg2+ in 
nucleotidyl transferases, such as polymerases, and generally results in faster catalysis. The 





Figure 1. Manganese reduces the dsDNA-length dependent response in vitro. 
A) recombinant cGASFL NTase activity was measured under steady state conditions in the 
presence or absence of 50uM and saturating levels of dsDNA. Reaction conditions: 100uM 
ATP/GTP, 10nM enzyme, 50nM PPiase; [dsDNA] = 6x Kact (Hooy and Sohn 2018).  
B) Hypothetical model of how Mn2+ ‘sensitizes’ cGAS to dsDNA. The allosteric equilibrium 
model posits that Mn2+ could affect auto-dimerization, ligand-induced dimerization, or catalytic 
rates. 
 
Manganese does not affect cGAS dimerization or its inherent binding affinity for dsDNA 
dsDNA length-dependent binding is directly linked to the extent by which a dsDNA stabilizes the 
dimeric state of cGAS (Hooy and Sohn 2018; Zhou et al. 2018). To test if Mn2+ enhances the 
ability of dsDNA to promote dimerization, different lengths of dsDNA were titrated against FRET-
pair-labeled cGASFL in the presence or absence of Mn2+ (Figure 2 – figure supplement 1A).  The 




,, nor the overall change in FRET, regardless of dsDNA length, indicating 
Mn2+ does not affect dsDNA-induced dimerization. Titrations of Mn2+ against fixed concentrations 
of dsDNA indicated no dose-dependent link between dsDNA length, dsDNA binding, or 
dimerization, further supporting this notion (Figure 2 – figure supplement 1B). Mn2+ was also 
incapable of promoting cGAS dimerization in the absence of dsDNA. Consistent with these 
observations, the binding affinity for FAM-labeled dsDNA was minimally impacted by the 
presence of Mn2+ (Figure 2 – figure supplement 1C). These data indicate that Mn2+ does not 
directly affect cGAS (dsDNA-induced) dimerization, nor the binding affinity for any length of 
dsDNA.  
 
Substrate binding is also linked to cGAS dimerization, and metals associate with substrates in the 
active site. Hence, it will be an important to test if Mn2+ can affect substrate-induced dimerization. 
This experiment will be performed in the future, and as described in Chapter 3. Briefly, ATP/GTP 
and their non-hydrolyzable analogues will be titrated against FRET-pair-labeled cGAS in the 





Figure 2 – figure supplement 1. Manganese does not enhance cGAS dimerization or dsDNA 
binding affinity. 
A) FRET of cGASFL as a function of dsDNA concentration in the presence and absence of 500uM 
Mn2+.  
B) FRET of cGASFL as a function of Mn2+ concentration in the absence of dsDNA.  
C) Change in fluorescence anisotropy of FAM-dsDNA19 in the presence and absence of 500uM 
Mn2+ as a function of cGASFL concentration. Data was fit with the Hill form of the binding 
equation: max / (1+(Kd / [cGAS





Manganese increases the catalytic turnover of dsDNA-bound cGAS 
Mn2+ can substitute for Mg2+ as a cofactor in many NTases, including cGAS (Gao, Ascano, et al. 
2013), and in several instances, promotes faster turnover of substrates (Frank and Woodgate 2007). 
To test if Mn2+ could affect the maximal turnover rate of cGAS, steady state activity was assayed 
as a function of Mn2+ concentration under saturating levels of short (19-bp, dsDNA19), medium 
(72-bp, dsDNA72) and long (339-bp, dsDNA339) dsDNA. Apparent rates increased hyperbolically 
with Mn2+ for all dsDNA lengths and produced 2-5-fold increases in maximal turnover, kmax, 
depending on the dsDNA length (Figure 2A, Figure 2 – figure supplement 2). The concentration 
of Mn2+ required to achieve half-maximal stimulation, EC50, was similar for the different dsDNA 
lengths, and fell within a range of 20-50uM. For comparison, the EC50 of Mg
2+ in the presence of 
long dsDNA was 3-4mM (Figure 2 – figure supplement 2A), illustrating a clear preference of Mn2+ 
over Mg2+. Moreover, the same Mn2+ titrations performed in the absence of free Mg2+ (low Mg2+) 
resulted in similar maximal turnover rates and EC50’s, but a more dramatic fold-change in activity 
due to reduced basal rates under low Mg2+ levels (Figure 2 – figure supplement 2). Interestingly, 
the maximal rates all peak around the same value, suggesting that under saturating dsDNA 
concentrations, Mn2+ nullifies differences between dsDNA lengths, consistent with the reduction 
of dsDNA length-dependence in cells.  
 
The observed increase in catalytic activity could result from increased binding affinity for 
substrates. To test this, steady state rates were measured as a function of ATP/GTP in the presence 
of saturating dsDNAs, with or without saturating levels of Mn2+ (Figure 2C, Figure 2 – figure 
supplement 2). Substrate utilization was cooperative in the absence of Mn2+ and maximal turnover, 
kcat, and substrate binding affinity, Km, were tiered with dsDNA length, as previously reported. In 
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the presence of Mn2+, apparent Kms were similar for each dsDNA activator relative to reactions 
without Mn2+, but the kcats were globally elevated. Notably, substrate utilization was not 
cooperative in the presence of Mn2+. Overall, the catalytic efficiency (kcat/Km) increased by a factor 
of 4-5 for each dsDNA, consistent with Figure 2A, and this is primarily achieved by increased 






Figure 2. Manganese increases the catalytic turnover of apo and dsDNA-bound cGAS. 
A) Steady-state rates of cGASFL as a function of Mn2+ concentration in 5mM Mg2+ buffer in the 
presence of saturating dsDNAs. Reaction conditions: 200uM ATP/GTP : 2 Mg2+, 25nM cGASFL, 
50nM PPiase; [dsDNA] = 6x Kact. Data were fit with the Hill form of the Michaelis-Menten 
equation: (kmax-kmin) * (1 / (1+(EC50 / [Mn
2+])Hill) + kmin. 
B) Steady-state rates of cGASFL and K394E-cGASFL as a function of Mn2+ concentration in 5mM 
Mg2+ buffer in the absence of dsDNAs. Reaction conditions: 200uM ATP/GTP : 2 Mg2+, 25nM 
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cGASFL, 50nM PPiase. Data were fit with the Hill form of the Michaelis-Menten equation: (kmax-
kmin) * (1 / (1+(EC50 / [Mn
2+])Hill) + kmin. 
C) Steady-state rates of cGASFL as a function of ATP/GTP concentration in 5mM Mg2+ buffer 
supplemented with or without 250uM Mn2+ and saturating levels of dsDNA. Reaction conditions: 
ATP/GTP : 2 Mg2+, 25nM cGAS, 50nM PPiase; [dsDNA] = 6x Kact. Data were fit with the Hill 
form of the Michaelis-Menten equation: kcat / (1+(Km / [ATP/GTP])
Hill). 
D) Steady-state rates of cGASFL and K394E-cGASFL as a function of ATP/GTP concentration in 
5mM Mn2+ buffer in the absence of dsDNA. Reaction conditions: ATP/GTP : 2 Mn2+, 25nM 







Figure 2 – figure supplement 2. Steady-state activity constants of cGASFL under various 
conditions. 
A) Steady-state activity of cGASFL as a function of Mg2+ in the presence of saturating dsDNA339. 
Reaction conditions: 200uM ATP/GTP : 2 Mg2+, 25nM cGASFL, 50nM PPiase. Data were fit with 
the Hill form of the Michaelis-Menten equation: (kmax-kmin) * (1 / (1+(EC50 / [Mn
2+])Hill) + kmin. 
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B) Steady-state rates of cGASFL as a function of ATP/GTP concentration in 5mM Mn2+ buffer and 
saturating levels of dsDNA. Reaction conditions: ATP/GTP : 2 Mn2+, 25nM cGAS, 50nM PPiase; 




Table 1. Mn2+ activation constants in reaction buffer containing no free Mg2+ or 5mM free Mg2+; 
from Figure 2.  
Table 2. Steady-state activity constants of cGASFL in the presence and absence of supplemented 
Mn2+; from Figure 2. 
Table 3. Steady-state activity constants of cGASFL in buffer containing no Mg2+ and 5mM Mn2+; 
from Figure 2. 
 
Note: The error is standard deviation of individual fits. Each experiment was performed at least 





Manganese activates monomeric cGAS even in the absence of dsDNA 
The Mn2+-specific increase in catalytic rate for all dsDNA lengths is confounded by the notion that 
Mn2+ does not directly affect cGAS dimerization. For instance, under saturating concentrations of 
short dsDNA, the fraction of dsDNA-bound dimers is presumed to be the same regardless of 
whether Mn2+ is present, yet the activity levels in the presence of Mn2+ increase substantially. 
Moreover, in the presence of long dsDNA, the dimeric fraction of cGAS is relatively high, yet the 
observed Mn2+-mediated NTase rate is similar to the value measured for shorter dsDNA activators. 
Finally, the reduced cooperativity of substrate utilization and Mn2+ binding hinted that dsDNA-
bound, dimeric cGAS may not be the only active species when Mn2+ was present.  
 
Although dsDNA is thought to be essential for cGAS activation, in principle, molecules within the 
active site can promote the same conformational changes induced by dsDNA binding (Hall, Brault, 
et al. 2017; Zhang et al. 2014). To test if dsDNA was required for Mn2+-mediated activity, cGAS 
NTase activity was again assayed as a function of Mn2+ concentration, but this time without 
dsDNA. Unexpectedly, Mn2+ alone was capable of inducing significant acceleration of NTase 
activity, with the EC50 resting around 1-2mM in the context of low and high free Mg
2+ (Figure 
2B). As expected, magnesium was unable to achieve activation of cGAS in the absence of dsDNA 
(Figure 2 – figure supplement 2A). The Hill coefficient was near 2 for Mn2+ suggesting the 
utilization of Mn2+ in the absence of dsDNA is cooperative. To test if Mn2+ was sufficient to 
activate cGAS in the complete absence of Mg2+, the steady state activity of cGAS was measured 
as a function of substrate concentration in buffer containing only Mn2+ (Figure 2D). Here, cGAS 
remained activated with Mn2+ alone and displayed rates comparable to those under saturating 
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concentrations of dsDNA. Remarkably, these observations indicate that Mn2+ can override the 
allosteric network, albeit only at concentrations well beyond those found in physiological settings.  
 
If dsDNA was no longer required for activation, it seemed logical to test whether dimerization was 
also dispensable for activation, given the thermodynamic linkage between dsDNA binding and 
dimerization. To test this, the NTase activity of dimerization-null mutant, K394E-cGASFL, was 
assayed. Mn2+ titrations showed a near identical trend relative to WT cGASFL indicating that Mn2+ 
could activate monomeric cGAS (Figure 2C). Substrate titrations in the presence of saturating 
Mn2+ and absence of Mg2+ (Figure 2D) also showed marked increases in catalytic efficiency 
confirming that dimerization is not required for auto-activation by Mn2+.  
 
Mn2+ binding is functionally coupled to dsDNA binding 
Although Mn2+ can auto-activate monomeric and dimeric cGAS, the concentration of Mn2+ 
required to achieve appreciable activity is not physiological (Bowman and Aschner 2014). 
However, the dramatic difference in functional binding affinity for Mn2+ in the presence and 
absence of dsDNA implied the existence of a thermodynamic linkage between the functional 
binding affinity of dsDNA and Mn2+. To test if Mn2+ could increase the functional binding affinity 
for dsDNA, the NTase activity of cGASFL was measured as a function of different dsDNAs in the 
presence and absence of Mn2+. cGASFL demonstrated increases in maximal catalytic turnover, kmax, 
in the presence of 50M Mn2+, consistent with Figure 2, but minimal changes in dsDNA functional 
binding affinity, Kact (Figure 3C, 3D). However, the minimal change in Kact
 could be misleading 
due to the sub-saturating Mn2+ levels and limited accessible range of binding affinities; the lowest 




To better quantify the extent by which Mn2+ could enhance dsDNA binding, cGAScat was assayed 
with saturating levels of Mn2+. cGAScat has weaker inherent binding affinity for dsDNA and would 
thus expand the range of experimentally accessible binding affinities, while saturating Mn2+ should 
maximize differences in binding affinity. We confirmed that cGAScat was activated by Mn2+ in a 
similar manner and extent as cGASFL (Figure 3 – figure supplement 1A). In the absence of Mn2+, 
cGAScat demonstrated dsDNA length-dependent activation; the concentration of dsDNA required 
to achieve half-maximal activation, Kact, was tiered with dsDNA length, consistent with our 
previous work (Figure 3A and 3B). In the presence of Mn2+, the maximal rates increased and the 
concentration of dsDNA required to achieve half-maximal activation was severely depressed. 
These results support the idea that Mn2+ binding is functionally coupled to dsDNA binding. The 
shift in Kact was seen for both dsDNA lengths and was similar in magnitude as the change in Mn
2+ 
EC50s, suggesting most of the coupling energy is accounted for by dsDNA and Mn
2+ cooperativity. 
Together, these data support the hypothesis that cGAS is sensitized by Mn2+ due to an intimate 
coupling between functional dsDNA binding and Mn2+ binding.    
 
The shift in Kact for short dsDNAs again suggested that monomeric cGAS may also be activated 
by dsDNA in the presence of Mn2+. Preliminary data with K394E-cGASFL and K394E-cGAScat 
suggests that dsDNA increases the efficiency of Mn2+ utilization (EC50) while reducing 
cooperativity, consistent with wild-type cGASFL (data not shown). This predicts that Mn2+ will 





Figure 3. Mn2+ enhances the functional binding affinity of dsDNA. 
A) Steady-state activity of cGAScat as a function of dsDNA19
 or B) dsDNA72 in 5mM Mg
2+ buffer 
in the presence and absence of 250M Mn2+. Reaction conditions: 100M ATP/GTP : 2 Mg2+, 
25nM cGAS, 50nM PPiase. Data were fit with the Hill form of the Michaelis-Menten equation: 
(kmax-kmin) * (1 / (1+(EC50 / [Mn
2+])Hill) + kmin. Parameters to the fits are shown in tables below 
each graph; n = 1.  
C) Steady-state activity of cGASFL as a function of dsDNA19
 or D) dsDNA339 in 5mM Mg
2+ buffer 
in the presence and absence of 50M Mn2+. Reaction conditions: 150 M ATP/GTP : 2 Mg2+, 
25nM cGAS, 50nM PPiase. Data were fit with the Hill form of the Michaelis-Menten equation: 
(kmax-kmin) * (1 / (1+(EC50 / [Mn





Figure 3 – figure supplement 1. Physiological concentrations of Mn2+ enhances catalytic 
turnover of cGASFL. 
A) Steady-state rates of cGAScat as a function of Mn2+ concentration in 5mM Mg2+ buffer in the 
presence of saturating dsDNA19. Reaction conditions: 200uM ATP/GTP : 2 Mg
2+, 25nM cGASFL, 
50nM PPiase; [dsDNA] = 6x Kact. Data were fit with the Hill form of the Michaelis-Menten 
equation: (kmax-kmin) * (1 / (1+(EC50 / [Mn
2+])Hill) + kmin; n = 1.  
Table 4. Steady-state activity constants of cGAScat in the presence and absence of 250 M Mn2+ 
as a function of dsDNA concentration; from Figure 3. The error is standard deviation of individual 
fits. Each experiment was performed at least three times. 
Table 5. Steady-state activity constants of cGASFL in the presence and absence of 50M Mn2+ as 




Manganese accelerates cGAMP production 
Enzymes that typically utilize Mg2+ as a Lewis acid often retain activity when Mg2+ is replaced 
with Mn2+. In the case of nucleotidyl transferases, Mn2+ substitution can result in faster turnover, 
but can also cause a reduction in product fidelity (Vaisman et al. 2005; Frank and Woodgate 2007; 
Vashishtha, Wang, and Konigsberg 2016; Crespan et al. 2016). Our PPiase-coupled assay 
demonstrates that Mn2+ supports faster turnover of substrate by cGAS, but it remained unclear 
whether cGAMP was the primary product of catalysis. To identify and quantify the products of 
catalysis, cGAS reactions were fractionated by HPLC. Synthetic standards and purified reaction 
products were used to determine the identity of individual species by matching retention times 
(Figure 4A). Exact mass will be used in the future to aid in peak identification. Consistent with 
previous literature, cGASFL stimulated by dsDNA under steady state conditions produced 
primarily two products in the presence of ATP/GTP, namely cGAMP and (likely) pppGpA (Figure 
4A) (Hall, Ralph, et al. 2017b). In the absence of dsDNA, cGASFL showed no detectable activity. 
Interestingly, the amount of cGAMP increased with dsDNA length (Figure 4B), while the pppGpA 
intermediate level was constant (Figure 4C). This observation highlights another key finding in 
cGAS dsDNA-length dependent signaling in that cGAMP production is tiered by the length of 
activating dsDNA.  Importantly, the differences in cGAMP levels between dsDNA lengths was 
reduced under conditions of high enzyme concentration (Figure 4D), reiterating the idea that 
dsDNA length-dependent activity is context-specific (Hooy and Sohn 2018). Of note, at higher 
cGAS concentrations, a pppGpG peak was present only for the short dsDNA activator (Figure 5 – 





Figure 4. In the absence of Mn2+, cGAMP levels tier with dsDNA length. 
A) Reverse phase HPLC fractionation of cGAS reaction components. Raw absorbance traces are 
shown for cGASFL in the presence and absence of saturating dsDNA. Standards of ATP, GTP and 
synthetic 2’, 3’ – cGAMP indicate respective retention times. Reaction conditions: 250M 
ATP/GTP : 2 Mg2+, 200nM cGASFL; [dsDNA] = 6x Kact, where indicated; reactions were run for 
2 hours prior to quenching, filtering and fractionation by HPLC. 
B) Zoom-in and overlay of the cGAMP peak and C) pppGpA peak for each of the reactions in a).  
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D) Integrated peak intensities of cGAMP (left) and pppGpA (right) for various reaction conditions. 
All reactions were run for 2 hours. Error bars indicate standard deviation of technical replicates.  
 
Next, we tested how Mn2+ affected the distribution of reaction products. cGASFL reactions 
supplemented with 50uM Mn2+ had a global increase in cGAMP and pppGpA levels for all dsDNA 
lengths (Figure 5A), in agreement with results obtained from the PPiase-coupled assay. For lower 
cGAS concentrations, this reduced the difference in cGAMP levels between long and short dsDNA 
from four-fold to two-fold. Importantly, this reduced length-dependence would imply that any 
residual dsDNA length dependence would result almost exclusively from differences in dsDNA 
binding affinity. Also of note, the pppGpG peak observed at high cGAS concentrations was 
reduced with Mn2+ present, suggesting that low levels of Mn2+ may also increase substrate 
stringency (see below) (Figure 5 – figure supplement 1). 
 
Although low levels of Mn2+ did not negatively skew the product fidelity, it remained unclear if 
high Mg2+ or dsDNA could be biasing substrate selection. Thus, reactions with and without dsDNA 
under auto-activating levels of Mn2+ were tested. cGASFL and K394E-cGASFL produced primarily 
on-pathway products without dsDNA, reiterating that cGAS preferentially couples ATP and GTP 
(Vincent et al. 2017) and that dsDNA is not required for cGAMP production (Figure 5). Reactions 
with dsDNA, however, did produce greater amounts of pppGpA (on-pathway) without greatly 
inflating total off-product synthesis (Figure 5 – figure supplement 1 Table). This suggests that 





dsDNA and Mn2+ promote ATP/GTP coupling under physiological conditions  
Thus far, our assays were performed with equimolar concentrations of ATP and GTP. However, 
in the cell, ATP outnumbers GTP by several fold (Traut 1994). Hence, even though cGAS 
demonstrated strong ATP/GTP coupling, it remained to be tested how Mn2+, cGAS concentration 
and dsDNA length affected substrate selection under more physiological conditions. Reactions 
with a 4:1 ratio of ATP to GTP were assessed for relative product distribution in the presence and 
absence of 50 M Mn2+ (Figure 5C). In the absence of Mn2+ cGAS produced primarily pppGpA 
and cGAMP, and some pppApA. When compared to Mn2+-supplemented reactions, despite 
elevated catalytic rates and relatively high ATP, only on-pathway products, pppGpA and cGAMP, 
were significantly elevated in the presence of Mn2+; pppApA levels were virtually unaffected by 
the addition of Mn2+. In contrast, under auto-activating levels of Mn2+, pppApA contributed 
significantly to the product pool (Figure 5D). However, the addition of dsDNA selectively 
promoted on-pathway catalysis, by reducing ATP/ATP coupling and increasing ATP/GTP pairing. 
These data emphasize that allosteric control of cGAS activity ensures high fidelity signaling by 




Figure 5. Mn2+ and dsDNA specifically enhance on-pathway catalysis. 
A) Normalized integrated peak intensities of cGAMP (left) and pppGpA (right) from reactions 
supplemented with or without 50M Mn2+. All reactions were run for 2 hours. Error bars indicate 
standard deviation of technical replicates.  
B) Raw absorbance traces of fractionated reaction components of K394E-cGASFL and cGASFL 
reactions under various conditions. Reaction conditions: 250M ATP/GTP : 2 Mg2+(lower two 
traces) or Mn2+ (upper two traces), 200nM cGAS; 5 g/ml dsDNA, where indicated; reactions were 
run for 2 hours prior to quenching, filtering and fractionation by HPLC. 
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C) Integrated peak intensities of cGAMP, pppGpA and pppApA for reactions supplemented with 
or without 50M Mn2+ in 5mM Mg2+ buffer. Reaction conditions: 1mM ATP : Mg2+, 250 M GTP 
: Mg2+, 200nM cGAS; 5 g/ml dsDNA, where indicated. Reactions were run for 2 hours.  
d) Integrated peak intensities of cGAMP, pppGpA and pppApA for reactions with or without 
dsDNA339 in 5mM Mn
2+ buffer. Reaction conditions: 1mM ATP : Mg2+, 250M GTP : Mg2+, 





Figure 5 – figure supplement 1. Mn2+ and dsDNA affect substrate selection. 
A) Raw absorbance traces of fractionated cGASFL reactions. Reactions contained different lengths 
of dsDNA in 5mM Mg2+ buffer in the presence and b) absence of 50M Mn2+. Reaction conditions: 
250M ATP/GTP : 2 Mg2+, 1M cGAS; dsDNA binding sites were in molar excess of cGAS by 
1.5-fold (1 binding site is equivalent to 18bps); reactions were run for 2 hours prior to quenching, 




Table 6. Integrated peak intensities of reaction products under auto-activating levels of Mn2+ for 
cGASFL in the presence and absence of dsDNA. Reaction conditions: 250M ATP/GTP : 2 Mn2+, 
200nM cGAS, 5g/ml dsDNA339 where indicated; where indicated; reactions were run for 2 hours 






Wang, et al. 2018 discovered an unidentified role of manganese in the innate immune response to 
pathogen challenge, and more generally, to cytosolic dsDNA. Although a clear relationship 
between the dsDNA sensor, cGAS, and manganese was established, the molecular mechanism by 
which manganese exerted its effects was ill-defined. Here, we determined the mechanism by which 
Mn2+ ‘sensitizes’ cGAS towards dsDNA.  
 
The effect of Mn2+-mediated activation 
We first established that Mn2+ enhances the activity of cGAS towards all lengths of dsDNA in vitro 
(Figure 1A). Moreover, cell-based experiments have shown that this effect can essentially 
eliminate the dsDNA length-dependent response in cells (data not shown; Chattergoon Lab). In 
principle, cGAS dsDNA length-dependent activity would be dictated by the concentration of 
cGAS and substrates in the cell (Hooy and Sohn 2018). cGAS is only marginally upregulated by 
interferon signaling (Ma et al. 2015), and our in vitro assays indicated that the effect of Mn2+ is 
achieved even with fixed levels of substrate (Figure 1A). This suggested then that Mn2+ likely 
affected an alternative aspect of the allosteric system, such as dimerization and/or catalytic states 
(Figure 1B). Mn2+ did not affect dimerization (Figure 2 – figure supplement 1). Instead, at high 
concentrations, Mn2+ was found to auto-activate monomeric and dimeric cGAS. This was 
somewhat surprising, given Wang, et al. 2018, failed to observe IRF3 phosphorylation in 
permeabilized THP-1 dual cells treated with cGAS reactions supplemented with auto-activating 
levels of Mn2+. Notably, the discrepancy is not due to an inability of auto-activated cGAS to 
produce cGAMP (Figure 5B). It is possible that the higher enzyme concentrations and elevated 
reaction temperatures used in the previous study had adverse effect on cGAS stability, that only 
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dsDNA (the cognate activator) could otherwise provide (Waldron and Murphy 2003; 
Cimmperman et al. 2008; Rupesh, Smith, and Boehmer 2014). It is worth noting, however, that 
HeLa cells significantly depleted of mitochondrial DNA still produced a Mn2+/cGAS-dependent 
response. This potentially suggests that auto-activation of cGAS can be achieved in cells, although 
it remains unclear if other sources of dsDNA contributed to the observed activity. Moreover, Mn2+ 
is a known mutagen (Demerec and Hanson 1951), and induction of the DNA-damage response 
could provide a source of cytosolic dsDNA, independent of reactive oxygen species (Wang, Guan, 
et al. 2018; Rodier et al. 2009; Hartlova et al. 2015; Yu et al. 2015).  
 
Although Mn2+ can auto-activate cGAS, the concentrations required to achieve meaningful activity 
are well-beyond those seen in physiology. However, we observed a strong functional coupling 
between dsDNA and Mn2+ supporting the idea that dsDNA may still be required to activate cGAS 
in cells. This coupled relationship also revealed that Mn2+ has a profound effect on the functional 
binding affinity for dsDNA, perhaps indicating how Mn2+ sensitizes cGAS to dsDNA. It remains 
unclear if the pronounced functional coupling occurs strictly in the dimer, or also within the 
monomer. One key experiment that will help answer this question is determining whether Mn2+ 
affects substrate-induced dimerization. Depending on the outcome, my data could support one of 
two models. If Mn2+ negligibly affects substrate-induced dimerization, it is likely that dsDNA-
bound monomeric cGAS is activated in the presence of Mn2+. If Mn2+ does positively affect 
substrate-induced dimerization, it is likely then that the Mn2+-substrate complex biases the 
allosteric equilibrium towards the dimeric state. In either case, each model would predict the 
following: a) in the presence of Mn2+ and saturating dsDNA, short dsDNAs activate cGAS as well 
as long dsDNAs, and b) cGAS displays Mn2+-dependent loss of cooperativity in substrate 
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utilization and dsDNA binding. The ‘active monomer’ model would also predict that a 
dimerization-null mutant would functionally couple dsDNA binding to Mn2+ utilization, whereas 
the ‘Mn2+-dimer’ model would predict that the mutant’s activity would be minimally impacted by 
the presence of dsDNA.  
 
Manganese as a cofactor 
Nucleotidyl transferases typically use magnesium as a cofactor for catalysis, but in many instances, 
manganese is a serviceable substitute (Vashishtha, Wang, and Konigsberg 2016), if not the 
preferential cofactor (Jiang et al. 2011). Many enzymes likely evolved to use magnesium as a 
cofactor due to its chemical properties and shear abundance in the cell. Cellular Mg2+ 
concentrations rest in the 5-20mM range (Romani and Scarpa 1992), whereas Mn2+ is rarely 
observed above 50 M. From the physical chemistry perspective, Mg2+ orbitals preferentially 
adopt the octahedral arrangements ideal for Lewis acid catalysis within the active site of 
polymerases. In contrast, Mn2+ can adopt alternative geometries and is more malleable with respect 
to ligand bond distances (Vashishtha, Wang, and Konigsberg 2016).  Thus, despite its similar 
effectiveness as a Lewis acid, it can reduce substrate restrictions, leading to misincorporation of 
cognate nucleotides by polymerases, for instance. cGAS produced significant amounts of pppApA 
when ATP was in excess over GTP. However, under low manganese concentrations, product 
fidelity was preserved even with excess ATP over GTP and faster overall catalytic rates. These 
observations indicate that the allosteric framework maintains the highest threshold for substrate 
selection.  
 
Manganese as an auto-activator  
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cGAS is unique in that its allosteric activator, dsDNA, regulates the spatial arrangement of its 
active site. In principle, molecules bound within the active site can promote the same re-
arrangement. Indeed, this effect likely contributes to the observed cooperativity between substrate 
and dsDNA binding. However, the observed auto-activation by Mn2+ suggests that Mn2+, in the 
presence of nucleotide, possesses the ability to not only stabilize the active, structured conformer 
of the activation loop, but also to trigger catalysis. It remains unclear if this effect is due to novel 
structural differences promoted by Mn2+ or discrepancies in substrate:metal binding kinetics.  
  
Efficient and effective signaling 
Here, we provide evidence to suggest that cGAS preferentially pairs ATP and GTP over either 
homo-dinucleotide pair, even in the presence of excess ATP and physiological levels of Mn2+. The 
proper selection of nucleotide pairs is paramount for cGAS for two main reasons. First, due to the 
relatively slow rate of catalysis, cGAS must perform high fidelity reactions to avoid wasted 
catalytic cycles. Second, human STING and its natural variants are hyper selective towards the 
identity of nucleobases and linkage within the cyclic dinucleotide (Ablasser et al. 2013; Diner et 
al. 2013; Zhang et al. 2013). Improper coupling of nucleotides by cGAS would impinge on its 
ability to effectively communicate the presence of stress. However, it remains unclear if cGAS 
actually maintains high levels of product fidelity in vivo, or if ‘sloppy’ catalysis is naturally built 
into the stress sensor. Evidence supporting this hypothesis is provided by the notable differences 
between mouse and human homologs of cGAS and STING. The mouse homolog of cGAS 
(mcGAS) turns over roughly ten-times faster than its human counterpart (Vincent et al. 2017; Zhou 
et al. 2018), and its downstream adaptor, mSTING, is activated by a broader range of cyclic 
dinucleotides (Zhang et al. 2013; Wang, Sinn, et al. 2017). This could imply that mcGAS produces 
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molecules other than 2’, 3’ cGAMP. Moreover, recent data suggests that mcGAS is less stringent 
towards short dsDNAs (Zhou et al. 2018). Thus, although speculative, it is possible that human 
cGAS and human STING co-evolved to be a more stringent signaling axis relative to its mouse 
ancestor. Future studies will reveal just how different the mouse and human systems are.  
 
The molecular basis of substrate selection 
Future work aims to more quantitatively determine the means by which ATP/GTP is preferentially 
selected for catalysis over alternative dinucleotide pairs. Based on our current knowledge, it is 
likely that substrate selection occurs at multiple steps within the allosteric network.  
 
Substrate-induced dimerization. cGAS FRET experiments have already begun to reveal that 
individual nucleotides differentially stabilize the cGAS dimeric state. For instance, ATP appears 
to be more ambivalent towards binding monomeric or dimeric cGAS relative to ATP/GTP. The 
same is not true for GTP. However, GTP is known to self-associate, especially at high 
concentrations and in the presence of potassium, and accurate interpretation of this data will 
require additional controls.  
 
Coupling to dsDNA binding. In reactions containing Mg2+, dsDNA length dictates the fraction of 
dimeric cGAS, which then dictates the apparent binding affinity for ATP/GTP, e.g. the apparent 
Km tiers with dsDNA length. It remains possible that the Km for ATP or GTP alone is dsDNA 
length-independent, which would skew the catalytic efficiency in favor of ATP/GTP. In reactions 
with high Mn2+, preliminary evidence suggests that ATP and GTP can be consumed on their own, 
albeit at relatively slower rates compared to ATP/GTP. Under low Mn2+ concentrations, the 
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relative difference in catalytic efficiencies will be dictated by how well dsDNA couples Mn2+ 
binding in the presence of ATP or GTP. For instance, when ATP/GTP is present, the EC50
 of Mn2+ 
drops by over an order of magnitude under conditions of saturating dsDNA. The same may not be 
true for ATP or GTP alone.  
 
 Catalytic turnover. It is clear from pilot experiments that turnover of GTP is slower than ATP 
which is slower than ATP/GTP. What remains unclear is by how much. Moreover, how alternative 
linear dinucleotide pairs affect the synthesis of cognate, pppGpA, remains untested.  
  
Cyclization of dinucleotide intermediates. Reactions containing auto-activating levels of Mn2+ and 
ATP were found to produce almost exclusively pppApA as product. This was surprising as the 
same reaction with GTP produced a more heterogeneous product distribution that included 
cyclized diGMP. This implies that cGAS has an intrinsic ability to stymie off-product pathways 
by reducing cyclization of off-pathway intermediates.   
 
Cyclic dinucleotide phosphodiester linkages. Although the synthetic 2’, 3’-cGAMP standard 
shares a similar retention time with the cGAMP molecules produced in reactions shown here, it 
remains to be seen whether the cGAMP molecules produced in the presence of Mn2+ are primarily 
2’, 3’-linked. Enzymatic digestion and analysis of purified cGAMP molecules will easily 





Metals play an essential role in biology. Dietary consumption provides the requisite intake of 
numerous cations that ultimately contribute to the maintenance of healthy tissues, cells, and a 
multitude of chemical processes. Unsurprisingly, metal deficiency or excess can lead to serious 
health issues. Moreover, proper usage, storage and disposal of metals is key for maintaining 
homeostasis. The results shown here reveal how metal selection can dictate how an enzyme is 
allosterically regulated. For cGAS, this could affect whether a cell commits to the antiviral 
response, senescence or cell death. It will be interesting to see if this phenomenon spans to other 





Materials and Methods 
Reagents 
See previous Chapter. Also, MnCl2 was purchased from Sigma. Tetrabutlyammonium hydrogen 
sulfate was from TCI America. Tris(2-carboxytheyl) phosphine (Tcep) was from Sigma. 2’,3’ 
cGAMP was from Invitrogen.  
 
Recombinant cGAS purification 
Protein preparation. See previous Chapter.  
Fluorophore labeling. See previous Chapter. 
 
Biochemical Assays 
All experiments were performed at least three times. The fits to data were generated using 
Kaleidagraph (synergy). Reported values are averages of at least three independent experiments 
and reported errors are standard deviations. All reactions were performed under 25 mM Tris 
acetate pH 7.4, 125 mM potassium acetate pH 7.4, 0.5mM Tcep, 5 mM MgCl2, and 5% glycerol 
at 25 ± 2 °C. cGAS concentrations are noted in the figure legends. 
 
dsDNA binding assays. See previous Chapter. Where indicated, experiments were performed in 
reaction buffer supplemented with MnCl2.  
 
FRET-based oligomerization assays. See previous Chapter. Where indicted, MnCl2 was 
supplemented into the reaction buffer. For Mn2+ titration experiments, dsDNA was included at 




Pyrophosphatase-coupled cGAS activity assay. See previous Chapter and Chapter 2 for full 
description. Average values and standard deviations are listed in Tables.  
 
Analytical fractionation of cGAS reactions by HPLC 
HPLC experiments were performed on the Agilent Technologies 120 Infinity II system using a 
Poroshell EC-C18 column (2.7m; 4.6x100mm). cGAS reactions were filtered with 10KDCO spin 
columns prior to loading onto the column. Reactions were fractionated by the following scheme: 
0% B from 0-1min, linear increase to 50% B from 1-27min, linear increase to 100% B from 27-
28min. Buffer A: 100mM potassium phosphate monobasic, 5mM TBA, pH 6.0; Buffer B: 100mM 
potassium phosphate monobasic, 5mM TBA, pH 6.0, 30% acetonitrile. Integrated peak intensities 
were calculated by the Agilent Technologies ChemStation software. Synthetic and purified 
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